Anton;huang2017.pdf;a bayesian simulation model for breast cancer screening incidence treatment and mortality;Huang, Xuelin, Li, Yisheng, Song, Juhee, Berry, Donald A.;2018
Noneg;carter2003.pdf;A computer model for the study of breast cancer;Carter KJ1, Castro F, Kessler E, Erickson B.;2003
q12;kulasingam2007.pdf;a cost-effectiveness analysis of adding a human papillomavirus vaccine to the australian national cervical cancer screening program;Kulasingam S1, Connelly L, Conway E, Hocking JS, Myers E, Regan DG, Roder D, Ross J, Wain G.;2007
q12;dee2009.pdf;a cost-utility analysis of adding a bivalent or quadrivalent hpv vaccine to the irish cervical screening programme;Eur J Public Health. 2010 Apr.20(2):213-9. doi: 10.1093/eurpub/ckp141. Epub 2009 Oct 28.;2877
q12;guerrero2015.pdf;a cost-utility analysis of cervical cancer screening and human papillomavirus vaccination in the philippines;Guerrero AM1, Genuino AJ1, Santillan M2, Praditsitthikorn N3, Chantarastapornchit V4, Teerawattananon Y5, Alejandria M6, Toral JA7.;2015
Anton;anonychuk2009.pdf;a cost-utility analysis of cervical cancer vaccination in preadolescent canadian females;Anonychuk AM1, Bauch CT, Merid MF, Van Kriekinge G, Demarteau N.;2009
q12;villanti2013.pdf;a cost-utility analysis of lung cancer screening and the additional benefits of incorporating smoking cessation interventions;PLoS One. 2013 Aug 7.8(8):e71379. doi: 10.1371/journal.pone.0071379. Print 2013.;2011
FromReview;khandker2000.pdf;A DECISION MODEL AND cost-effectiveness ANALYSIS OF COLORECTAL CANCER SCREENING AND SURVEILLANCE GUIDELINES FOR AVERAGE-RISK ADULTS;;
Anton;berg2009.pdf;a discrete event simulation model to evaluate operational performance of a colonoscopy suite;Berg B., Denton B., Nelson H., Balasubramanian H., Rahman A., Bailey A., Lindor K.;2010
Anton;akhavantabatabaei2016.pdf;a markov decision process model for cervical cancer screening policies in colombia;Akhavan-Tabatabaei R., Sanchez D.M., Yeung T.G.;2016
FromReview;plevritis2001.pdf;A mathematical algorithm that computes breast cancer sizes and doubling times detected by screening.;;
Noneg;caleffi2009.pdf;a model to optimize public health care and downstage breast cancer in limited-resource populations in southern brazil porto alegre breast health intervention cohort;Caleffi M1, Ribeiro RA, Duarte Filho DL, Ashton-Prolla P, Bedin AJ Jr, Skonieski GP, Zignani JM, Giacomazzi J, Franco LR, Graudenz M, Pohlmann P, Fernandes JG, Kivitz P, Weber B.;2009
FromReview;shen2005.pdf;a model-based comparison of breast cancer screening strategies mammograms and clinical breast examinations;Shen, Y  Parmigiani, G;2005
Anton;kolevakolarova2018.pdf;a modelling study to evaluate the costs and effects of lowering the starting age of population breast cancer screening;Maturitas. 2018 Mar.109:81-88. doi: 10.1016/j.maturitas.2017.12.009. Epub 2017 Dec 15.;2017
Anton;plevritis2006.pdf;a natural history model of stage progression applied to breast cancer;Plevritis S.K., Salzman P., Sigal B.M., Glynn P.W.;2007
Anton;draisma2013.pdf;a note on the catch-up time method for estimating lead or sojourn time in prostate cancer screening;Draisma, Gerrit  van Rosmalen, Joost;2013
Anton;goldie2003.pdf;a potential error in evaluating cancer screening a comparison of 2 approaches for modeling underlying disease progression;Goldie S.J., Kuntz K.M.;2003
Noneg;wu2009.pdf;a projection of benefits due to fecal occult blood test for colorectal cancer;Wu D1, Erwin D, Rosner GL.;2009
FromReview;hassan2010.pdf;A Resect and Discard Strategy Would Improve cost-effectiveness ofColorectal Cancer Screening;;
FromReview;3001506.pdf;A review and critique of modelling in prioritising and designing screening programmes;;
Anton;haug2005.pdf;a simulation model for colorectal cancer screening potential of stool tests with various performance characteristics compared with screening colonoscopy;Haug, U  Brenner, H;2005
Noneg;lejeune2003.pdf;A simulation model for evaluating the medical and economic outcomes of screening strategies for colorectal cancer;Lejeune C1, Arveux P, Dancourt V, Fagnani F, Bonithon-Kopp C, Faivre J.;2003
FromReview;bailey2010.pdf;a simulation model investigating the impact of tumor volume doubling time and mammographic tumor detectability on screening outcomes in women aged 40-49 years;Bailey, Stephanie L.  Sigal, Bronislava M.  Plevritis, Sylvia K.;2010
Anton;palma2015.pdf;a system dynamics model of serum prostate-specific antigen screening for prostate cancer;Palma, Anton  Lounsbury, David W.  Schlecht, Nicolas F.  Agalliu, Ilir;2016
FromReview;kuntz2011.pdf;A Systematic Comparison of Microsimulation Models of Colorectal Cancer: The Role of Assumptions about Adenoma Progression;;
Anton;stollenwerk2012.pdf;accounting for increased non-target-disease-specific mortality in decision-analytic screening models for economic evaluation;Stollenwerk, Bjoern  Gandjour, Afschin  Luengen, Markus  Siebert, Uwe;2013
FromReview;balasubramanian2010.pdf;Accuracy and cost-effectiveness of Cervical Cancer Screening by High-Risk Human Papillomavirus DNA Testing of Self-Collected Vaginal Samples;;
Anton;mcmahon2008.pdf;Adopting Helical CT Screening for Lung Cancer Potential Health Consequences During a 15-Year Period;McMahon PM1, Kong CY, Weinstein MC, Tramontano AC, Cipriano LE, Johnson BE, Weeks JC, Gazelle GS.;2008
Anton;sepp2015.pdf;age-related incidence of cervical cancer supports two aetiological components a population-based register study;Seppa K., Pitkaniemi J., Malila N., Hakama M.;2016
Noneg;chen2010.pdf;alexithymia as a screening index for male conscripts with adjustment disorder;Chen P.-F., Chen C.-S., Chen C.-C., Lung F.-W.;2011
Anton;10.1109@42.932741.pdf;an artificial intelligent algorithm for tumor detection in screening mammogram;Zheng, L  Chan, AK;2001
Noneg;arrospide2013.pdf;An assessment of existing models for individualized breast cancer risk estimation in a screening program in Spain;Arrospide A, Forn?? C, Ru?? M, Tor? N, Mar J, Bar?? M1.;2013
Anton;pinsky2004.pdf;An Early- and Late-Stage Convolution Model for Disease Natural History;Pinsky PF1.;2004
Anton;witte2017.pdf;an em algorithm for nonparametric estimation of the cumulative incidence function from repeated imperfect test results;Witte BI1, Berkhof J1, Jonker MA1,2.;2017
FromReview;sherlawjohnson2004.pdf;An evaluation of liquid-based cytology and human papillomavirus testing within the UK cervical cancer screening programme;;
Noneg;rutter2010.pdf;an evidence-based microsimulation model for colorectal cancer validation and application;Rutter, Carolyn M., Savarino, James E.;2010
Anton;levin2015.pdf;an extended cost-effectiveness analysis of publicly financed hpv vaccination to prevent cervical cancer in china;Levin CE1, Sharma M2, Olson Z3, Verguet S4, Shi JF5, Wang SM5, Qiao YL5, Jamison DT3, Kim JJ6.;2015
Noneg;chiu2010.pdf;analytical decision model for sample size and effectiveness projections for use in planning a population-based randomized controlled trial of colorectal cancer screening;Chiu, Sherry Y-H, Malila, Nea, Yen, Amy M-F, Anttila, Ahti, Hakama, Matti, Chen, H-H;2011
Noneg;lee2016.pdf;annual combined mammography and tomosynthesis screening is it really cost-effective;Lee CI1,2,3, Lee JM1,3, Tosteson AN4.;2016
Noneg;ma2013.pdf;annual number of lung cancer deaths potentially avertable by screening in the united states;Cancer. 2013 Apr 1.119(7):1381-5. doi: 10.1002/cncr.27813. Epub 2013 Feb 25.;2002
Anton;petry2013.pdf;Annual Papanicolaou screening for 5 years among human papillomavirus-negative women;Petry, Karl Ulrich  Rinnau, Franziska  Boehmer, Gerd  Hollwitz, Bettina  Luyten, Alexander  Buttmann, Nina  Bruenger, Martin  Iftner, Thomas;2013
Anton;edwards2010.pdf;annual report to the nation on the status of cancer 1975-2006 featuring colorectal cancer trends and impact of interventions risk factors screening and treatment to reduce future rates;Edwards BK1, Ward E, Kohler BA, Eheman C, Zauber AG, Anderson RN, Jemal A, Schymura MJ, Lansdorp-Vogelaar I, Seeff LC, van Ballegooijen M, Goede SL, Ries LA.;2010
Anton;borrs1998.pdf;anticipating the consequences for the primary therapy of breast cancer after introducing screening - a more global picture for health care policy making;Borras, JM  Espinas, JA  Beemsterboer, PMM  Granados, A  de Koning, HJ;1998
Anton;ijpr-14-635.pdf;applying a simple model of cost-effectiveness study of hpv vaccine for iran;Khatibi M., Rasekh H.R.;2015
Noneg;zai2014.pdf;applying operations research to optimize a novel population management system for cancer screening;Zai, Adrian H., Kim, Seokjin, Kamis, Arnold, Hung, Ken, Ronquillo, Jeremiah G., Chueh, Henry C., Atlas, Steven J.;2014
q12;ladabaum2001.pdf;aspirin as an adjunct to screening for prevention of sporadic colorectal cancer a cost-effectiveness analysis;Ladabaum U1, Chopra CL, Huang G, Scheiman JM, Chernew ME, Fendrick AM.;2001
Anton;hsieh2002.pdf;assessing chronic disease progression using non-homogeneous exponential regression markov models an illustration using a selective breast cancer screening in taiwan;Hsieh, HJ  Chen, THH  Chang, SH;2002
Anton;andersson2017.pdf;assessment of lead-time bias in estimates of relative survival for breast cancer;Andersson TM1, Rutherford MJ2, Humphreys K3.;2017
q12;steens2012.pdf;association between human papillomavirus vaccine uptake and cervical cancer screening in the netherlands implications for future impact on prevention;Steens A1, Wielders CC, Bogaards JA, Boshuizen HC, de Greeff SC, de Melker HE.;2013
Anton;plevritis2018.pdf;association of screening and treatment with breast cancer mortality by molecular subtype in us women 2000-2012;Plevritis, Sylvia K.  Munoz, Diego  Kurian, Allison W.  Stout, Natasha K.  Alagoz, Oguzhan  Near, Aimee M.  Lee, Sandra J.  van den Broek, Jeroen J.  Huang, Xuelin  Schechter, Clyde B.  Sprague, Brian L.  Song, Juhee  de Koning, Harry J.  Trentham-Dietz, Amy  van Ravesteyn, Nicolien T.  Gangnon, Ronald  Chandler, Young  Li, Yisheng  Xu, Cong  Ergun, Mehmet Ali  Huang, Hui  Berry, Donald A.  Mandelblatt, Jeanne S.;2018
Anton;lansdorpvogelaar2009.pdf;at what costs will screening with ct colonography be competitive a cost-effectiveness approach;Lansdorp-Vogelaar, Iris  van Ballegooijen, Marjolein  Zauber, Ann G.  Boer, Rob  Wischut, Janneke  Habbema, J. Dik F.;2009
Noneg;armero2008.pdf;bayesian assessment of times to diagnosis in breast cancer screening;Armero, Carmen, Lopez-Quilez, Antonio, Lopez-Sanchez, Rut;2008
FromReview;myles2003.pdf;Bayesian evaluation of breast cancer screening using data from two studies;;
Noneg;hsu2017.pdf;bayesian negative-binomial-family-based multistate markov model for the evaluation of periodic population-based cancer screening considering incomplete information and measurement errors;Hsu, Chen-Yang, Yen, Ming-Fang, Auvinen, Anssi, Chiu, Yueh-Hsia, Chen, Hsiu-Hsi;2018
Anton;hsieh2013.pdf;bayesian spatial analysis for the evaluation of breast cancer detection methods;Hsieh, Jeff Ching-Fu  Cramb, Susanna M.  McGree, James M.  Baade, Peter D.  Dunn, Nathan A. M.  Mengersen, Kerrie L.;2013
Noneg;mandelblatt2002.pdf;Benefits and costs of using HPV testing to screen for cervical cancer.;Mandelblatt JS1, Lawrence WF, Womack SM, Jacobson D, Yi B, Hwang YT, Gold K, Barter J, Shah K.;2002
Anton;10.1093@jnci@djv103.pdf;benefits and harms of mammography screening after age 74 years model estimates of overdiagnosis;van Ravesteyn, Nicolien T.  Stout, Natasha K.  Schechter, Clyde B.  Heijnsdijk, Eveline A. M.  Alagoz, Oguzhan  Trentham-Dietz, Amy  Mandelblatt, Jeanne S.  de Koning, Harry J.;2015
Anton;sprague2015.pdf;Benefits, Harms, and cost-effectiveness of Supplemental Ultrasonography Screening for Women With Dense Breasts;Sprague BL, Stout NK, Schechter C, van Ravesteyn NT, Cevik M, Alagoz O, Lee CI, van den Broek JJ, Miglioretti DL, Mandelblatt JS, de Koning HJ, Kerlikowske K, Lehman CD, Tosteson AN.;2015
Noneg;10.1177@0969141316668379.pdf;breast cancer incidence trends in norway and estimates of overdiagnosis;van Luijt PA1, Heijnsdijk EA1, van Ravesteyn NT1, Hofvind S2, de Koning HJ1.;2017
Noneg;vacek2011.pdf;breast cancer risk assessment in women aged 70 and older;Vacek PM1, Skelly JM, Geller BM.;2011
Noneg;timmers2013.pdf;breast cancer risk prediction model a nomogram based on common mammographic screening findings;Timmers JM1, Verbeek AL, IntHout J, Pijnappel RM, Broeders MJ, den Heeten GJ.;2013
FromReview;okonkwo2008.pdf;breast cancer screening policies in developing countries a cost-effectiveness analysis for india;Okonkwo, Quirine Lamberts  Draisma, Gerrit  der Kinderen, Arno  Brown, Martin L.  de Koning, Harry J.;2008
Anton;weedonfekjr2008.pdf;breast cancer tumor growth estimated through mammography screening data;Weedon-Fekjaer, Harald  Lindqvist, Bo H.  Vatten, Lars J.  Aalen, Odd O.  Tretli, Steinar;2008
Noneg;michaelson1999.pdf;Breast cancer: computer simulation method for estimating optimal intervals for screening.;;1999
Noneg;arveux2003.pdf;building a model to determine the cost-effectiveness of breast cancer screening in france;Arveux P1, Wait S, Schaffer P.;2003
q12;carreras2012.pdf;can a national lung cancer screening program in combination with smoking cessation policies cause an early decrease in tobacco deaths in italy;Cancer Prev Res (Phila). 2012 Jun.5(6):874-82. doi: 10.1158/1940-6207.CAPR-12-0019. Epub 2012 Apr 23.;2015
Noneg;dolan2013.pdf;can streamlined multicriteria decision analysis be used to implement shared decision making for colorectal cancer screening;Dolan JG1, Boohaker E2, Allison J3, Imperiale TF4.;2014
Anton;saini2013.pdf;can the adenoma detection rate reliably identify low-performing endoscopists results of a modeling study;Saini S.D., Schoenfeld P., Vijan S.;2013
Anton;dhar2018.pdf;Catalyzing Novel Approaches to Rapid, Accurate, and Affordable Early Cancer Detection;Dhar, Asif  Meagher, Beth  Ryscavage, Andrew;2018
FromReview;creighton2010.pdf;Cervical cancer screening in Australia: modelled evaluation of the impact of changing the recommended interval from two to three years;;
Anton;campos2015.pdf;cervical cancer screening in low-resource settings a cost-effectiveness framework for valuing tradeoffs between test performance and program coverage;Campos, Nicole G.  Castle, Philip E.  Wright, Thomas C., Jr.  Kim, Jane J.;2015
Noneg;wang2018.pdf;Challenges and research opportunities for lung cancer screening in China;Wang, Zixing, Wang, Yuyan, Huang, Yao, Xue, Fang, Han, Wei, Hu, Yaoda, Wang, Lei, Song, Wei, Jiang, Jingmei;2018
Anton;ekwunife2016.pdf;challenges in cost-effectiveness analysis modelling of hpv vaccines in low- and middle-income countries a systematic review and practice recommendations;Ekwunife OI1,2, O'Mahony JF3, Gerber Grote A4,5, Mosch C6, Paeck T7, Lhachimi SK8,7.;2017
Anton;schultz2012.pdf;chapter 7 description of miscan-lung the erasmus mc lung cancer microsimulation model for evaluating cancer control interventions;Schultz FW1, Boer R, de Koning HJ.;2012
Anton;nihms408197.pdf;chapter 9 the mgh-hms lung cancer policy model tobacco control versus screening;McMahon PM1, Kong CY, Johnson BE, Weinstein MC, Weeks JC, Tramontano AC, Cipriano LE, Bouzan C, Gazelle GS.;2012
Noneg;10.1177@0272989x11408915.pdf;clarifying differences in natural history between models of screening the case of colorectal cancer;van Ballegooijen, Marjolein, Rutter, Carolyn M., Knudsen, Amy B., Zauber, Ann G., Savarino, James E., Lansdorp-Vogelaar, Iris, Boer, Rob, Feuer, Eric J., Habbema, J. Dik F., Kuntz, Karen M.;2011
Noneg;prakash2017.pdf;cmost an open-source framework for the microsimulation of colorectal cancer screening strategies;Prakash, Meher K., Lang, Brian, Heinrich, Henriette, Valli, Piero V., Bauerfeind, Peter, Sonnenberg, Amnon, Beerenwinkel, Niko, Misselwitz, Benjamin;2017
FromReview;hassan2007.pdf;Colon cancer prevention in Italy: cost-effectiveness analysis with CT colonography and endoscopy;;
FromReview;nejmoa054967.pdf;Colonoscopy in Colorectal-Cancer Screening for Detection of Advanced Neoplasia;;
FromReview;mandel1999.pdf;Colorectal Cancer Mortality: Effectiveness of Biennial Screening for Fecal Occult Blood;;
Anton;ladabaum2006.pdf;colorectal cancer screening - differential costs for younger versus older americans;Ladabaum, U  Phillips, KA;2006
Noneg;joseph2016.pdf;colorectal cancer screening estimated future colonoscopy need and current volume and capacity;Joseph, Djenaba A., Meester, Reinier G. S., Zauber, Ann G., Manninen, Diane L., Winges, Linda, Dong, Fred B., Peaker, Brandy, van Ballegooijen, Marjolein;2016
Anton;wolf2018.pdf;colorectal cancer screening for average-risk adults 2018 guideline update from the american cancer society;Wolf, Andrew M. D.  Fontham, Elizabeth T. H.  Church, Timothy R.  Flowers, Christopher R.  Guerra, Carmen E.  LaMonte, Samuel J.  Etzioni, Ruth  McKenna, Matthew T.  Oeffinger, Kevin C.  Shih, Ya-Chen Tina  Walter, Louise C.  Andrews, Kimberly S.  Brawley, Otis W.  Brooks, Durado  Fedewa, Stacey A.  Manassaram-Baptiste, Deana  Siegel, Rebecca L.  Wender, Richard C.  Smith, Robert A.;2018
FromReview;heitman2010.pdf;Colorectal Cancer Screening for Average-Risk North Americans: An Economic Evaluation;;
Noneg;stone2004.pdf;colorectal cancer screening in australia an economic evaluation of a potential biennial screening program using faecal occult blood tests;Stone CA1, Carter RC, Vos T, John JS.;2004
Noneg;lee2007.pdf;colorectal cancer screening using fecal occult blood test and subsequent risk of colorectal cancer a prospective cohort study in japan;Lee KJ1, Inoue M, Otani T, Iwasaki M, Sasazuki S, Tsugane S. Japan Public Health Center-based Prospective Study.;2007
Noneg;10.1.1.557.8022.pdf;Colorectal cancer screening with faecal occult blood test within a multiple disease screening programme: an experience from Keelung, Taiwan;;2006
Anton;mcleod2017.pdf;Colorectal cancer screening: How health gains and cost-effectiveness vary by ethnic group, the impact on health inequalities, and the optimal age-range to screen;McLeod M., Kvizhinadze G., Boyd M., Barendregt J., Sarfati D., Wilson N., Blakely T.;2017
FromReview;gyrdhansen1998.pdf;COLORECTAL CANCER SCREENING:EFFICIENCY AND EFFECTIVENESS;;
FromReview;pence2012.pdf;Combination Aspirin and/or Calcium Chemoprevention with Colonoscopy in Colorectal Cancer Prevention: cost-effectiveness Analyses;;
Anton;meza2014.pdf;comparative analysis of 5 lung cancer natural history and screening models that reproduce outcomes of the nlst and plco trials;Meza, Rafael  ten Haaf, Kevin  Kong, Chung Yin  Erdogan, Ayca  Black, William C.  Tammemagi, Martin C.  Choi, Sung Eun  Jeon, Jihyoun  Han, Summer S.  Munshi, Vidit  van Rosmalen, Joost  Pinsky, Paul  McMahon, Pamela M.  de Koning, Harry J.  Feuer, Eric J.  Hazelton, William D.  Plevritis, Sylvia K.;2014
Anton;landy2017.pdf;comparative effectiveness and cost-effectiveness of a multitarget stool dna test to screen for colorectal neoplasia;Gastroenterology. 2016 Sep.151(3):427-439.e6. doi: 10.1053/j.gastro.2016.06.003. Epub 2016 Jun 14.;2016
FromReview;vickers2013.pdf;comparative effectiveness of alternative prostate-specific antigen-based prostate cancer screening strategies model estimates of potential benefits and harms;Gulati, Roman  Gore, John L.  Etzioni, Ruth;2013
Anton;trenthamdietz2017.pdf;Comparative effectiveness of incorporating a hypothetical DCIS prognostic marker into breast cancer screening;Trentham-Dietz, Amy  Ergun, Mehmet Ali  Alagoz, Oguzhan  Stout, Natasha K.  Gangnon, Ronald E.  Hampton, John M.  Dittus, Kim  James, Ted A.  Vacek, Pamela M.  Herschorn, Sally D.  Burnside, Elizabeth S.  Tosteson, Anna N. A.  Weaver, Donald L.  Sprague, Brian L.;2018
Anton;10.1002@cncr.31141.pdf;comparative effectiveness of prostate cancer screening between the ages of 55 and 69 years followed by active surveillance;de Carvalho, Tiago M., Heijnsdijk, Eveline A. M., de Koning, Harry J.;2018
FromReview;ross2000.pdf;Comparative efficiency of prostate-specific antigen screening strategies for prostate cancer detection.;;
Anton;mcmahon2014.pdf;comparing benefits from many possible computed tomography lung cancer screening programs extrapolating from the national lung screening trial using comparative modeling;McMahon, Pamela M.  Meza, Rafael  Plevritis, Sylvia K.  Black, William C.  Tammemagi, C. Martin  Erdogan, Ayca  ten Haaf, Kevin  Hazelton, William  Holford, Theodore R.  Jeon, Jihyoun  Clarke, Lauren  Kong, Chung Yin  Choi, Sung Eun  Munshi, Vidit N.  Han, Summer S.  van Rosmalen, Joost  Pinsky, Paul F.  Moolgavkar, Suresh  de Koning, Harry J.  Feuer, Eric J.;2014
Noneg;10.1177@0272989x17718168.pdf;comparing cisnet breast cancer incidence and mortality predictions to observed clinical trial results of mammography screening from ages 40 to 49;van den Broek, Jeroen J., van Ravesteyn, Nicolien T., Mandelblatt, Jeanne S., Huang, Hui, Ergun, Mehmet Ali, Burnside, Elizabeth S., Xu, Cong, Li, Yisheng, Alagoz, Oguzhan, Lee, Sandra J., Stout, Natasha K., Song, Juhee, Trentham-Dietz, Amy, Plevritis, Sylvia K., Moss, Sue M., de Koning, Harry J.;2018
q12;lin2011.pdf;comparing the benefits of screening for breast cancer and lung cancer using a novel natural history model;Lin, Ray S., Plevritis, Sylvia K.;2012
Anton;silva2016.pdf;comparison of markov models used for the economic evaluation of colorectal cancer screening a systematic review;Silva, N. S.;2016
Anton;kafadar2005.pdf;computational methods in medical decision making to screen or not to screen;Kafadar, K  Prorok, C;2005
Noneg;kerlikowske1999.pdf;Continuing screening mammography in women aged 70 to 79 years: impact on life expectancy and cost-effectiveness.;JAMA. 1999 Dec 8.282(22):2156-63.;1000
Anton;lansdorpvogelaar2012.pdf;contribution of screening and survival differences to racial disparities in colorectal cancer rates;Lansdorp-Vogelaar, Iris  Kuntz, Karen M.  Knudsen, Amy B.  van Ballegooijen, Marjolein  Zauber, Ann G.  Jemal, Ahmedin;2012
Noneg;bech2000.pdf;cost implications of routine mammography screening of women 50-69 years in the county of funen denmark;Bech M., Gyrd-Hansen D.;2000
Noneg;lejeune2004.pdf;cost-effective analysis of fecal occult blood screening for colorectal cancer;Lejeune, C, Arveux, P, Dancourt, V, Bejean, S, Bonithon-Kopp, C, Faivre, J;2004
Noneg;manuel2004.pdf;cost-effectiveness analyses in gynecologic oncology methodological quality and trends;Manuel MR1, Chen LM, Caughey AB, Subak LL.;2004
FromReview;chen2007.pdf;cost-effectiveness analysis for determining optimal cut-off of immunochemical faecal occult blood test for population-based colorectal cancer screening (KCIS 16);;
Anton;chen2011.pdf;cost-effectiveness analysis for pap smear screening and human papillomavirus dna testing and vaccination;Chen, Meng-Kan  Hung, Hui-Fang  Duffy, Stephen  Yen, Amy Ming-Fang  Chen, Hsiu-Hsi;2011
Anton;reynalesshigematsu2009.pdf;cost-effectiveness analysis of a quadrivalent human papilloma virus vaccine in mexico;Reynales-Shigematsu LM1, Rodrigues ER, Lazcano-Ponce E.;2009
Anton;neeser2007.pdf;cost-effectiveness analysis of a quality-controlled mammography screening program from the swiss statutory health-care perspective quantitative assessment of the most influential factors;Neeser, Kurt  Szucs, Thomas  Bulliard, Jean-Luc  Bachmann, Gaudenz  Schramm, Wendelin;2007
Anton;szucs2008.pdf;cost-effectiveness analysis of adding a quadrivalent hpv vaccine to the cervical cancer screening programme in switzerland;Szucs T.D., Largeron N., Dedes K.J., Rafia R., Benard S.;2008
Noneg;cromwell2016.pdf;cost-effectiveness analysis of anal cancer screening in women with cervical neoplasia in british columbia canada;Cromwell I1,2, Gaudet M3,4, Peacock SJ5,6,7, Aquino-Parsons C3.;2016
Anton;wu2006.pdf;cost-effectiveness analysis of colorectal cancer screening with stool dna testing in intermediate-incidence countries;Wu, Grace Hui-Min  Wang, Yi-Ming  Yen, Amy Ming-Fang  Wong, Jau-Min  Lai, Hsin-Chih  Warwick, Jane  Chen, Tony Hsiu-Hsi;2006
q12;mo2017.pdf;cost-effectiveness analysis of different types of human papillomavirus vaccination combined with a cervical cancer screening program in mainland china;;2017
Noneg;10.5888@pcd14.160158.pdf;cost-effectiveness analysis of four simulated colorectal cancer screening interventions north carolina;Lich, Kristen Hassmiller, Cornejo, David A., Mayorga, Maria E., Pign Michael, Tangka, Florence K. L., Richardson, Lisa C., Kuo, Tzy-Mey, Meyer, Anne-Marie, Hall, Ingrid J., Smith, Judith Lee, Durham, Todd A., Chall, Steven A., Crutchfield, Trisha M., Wheeler, Stephanie B.;2017
q12;obradovic2010.pdf;cost-effectiveness analysis of hpv vaccination alongside cervical cancer screening programme in slovenia;Obradovic M1, Mrhar A, Kos M.;2010
Noneg;hkm1006sp3p38.pdf;cost-effectiveness analysis of mammography screening in Hong Kong Chinese using state-transition Markov modelling;Research Support, Non-U.S. Gov't,Adult,Age Factors,Aged,Breast Neoplasms/economics*,Breast Neoplasms/ethnology,Breast Neoplasms/prevention & control*,Cost-Benefit Analysis,Early Detection of Cancer/economics*,Female,Hong Kong,Humans,Longitudinal Studies,Mammography/economics*,Markov Chains,Mass Screening/economics*,Mass Screening/methods,Middle Aged;2060
Anton;konno2010.pdf;cost-effectiveness analysis of prophylactic cervical cancer vaccination in japanese women;Konno R1, Sasagawa T, Fukuda T, Van Kriekinge G, Demarteau N.;2010
Anton;manser2005.pdf;cost-effectiveness analysis of screening for lung cancer with low dose spiral ct computed tomography in the australian setting;Manser, R  Dalton, A  Carter, R  Byrnes, G  Elwood, M  Campbell, DA;2005
Anton;bergeron2008.pdf;cost-effectiveness analysis of the introduction of a quadrivalent human papillomavirus vaccine in france;Bergeron C1, Largeron N, McAllister R, Mathevet P, Remy V.;2008
Noneg;berchi2004.pdf;cost-effectiveness analysis of two strategies for mass screening for colorectal cancer in france;Berchi, C, Bouvier, V, Reaud, JM, Launoy, G;2004
Noneg;tsoi2008.pdf;cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in asia;;2008
Noneg;arrospide2018.pdf;cost-effectiveness and budget impact analyses of a colorectal cancer screening programme in a high adenoma prevalence scenario using miscan-colon microsimulation model;Arrospide, Arantzazu, Idigoras, Isabel, Mar, Javier, de Koning, Harry, van der Meulen, Miriam, Soto-Gordoa, Myriam, Miguel Martinez-Llorente, Jose, Portillo, Isabel, Arana-Arri, Eunate, Ibarrondo, Oliver, Lansdorp-Vogelaar, Iris;2018
Noneg;pil2016.pdf;cost-effectiveness and budget impact analysis of a population-based screening program for colorectal cancer;Pil L1, Fobelets M2, Putman K3, Trybou J4, Annemans L5.;2016
Anton;cleemput2009.pdf;cost-effectiveness Evaluation of a Quadrivalent Human Papillomavirus Vaccine in Belgium;Annemans L., Remy V., Oyee J., Largeron N.;2009
Noneg;lucidarme2012.pdf;cost-effectiveness modeling of colorectal cancer computed tomography colonography vs colonoscopy or fecal occult blood tests;Lucidarme O1, Cadi M, Berger G, Taieb J, Poynard T, Grenier P, Beresniak A.;2012
Anton;schillerfrhwirth2017.pdf;cost-effectiveness models in breast cancer screening in the general population a systematic review;Schiller-Fruethwirth, Irmgard C.  Jahn, Beate  Arvandi, Marjan  Siebert, Uwe;2017
FromReview;chuck2010.pdf;cost-effectiveness of 21 Alternative Cervical Cancer Screening Strategies;;
q12;sopina2011.pdf;cost-effectiveness of a cervical screening program with human papillomavirus vaccine;Sopina E1, Ashton T.;2011
Noneg;sonnenberg2002.pdf;cost-effectiveness of a single colonoscopy in screening for colorectal cancer;Sonnenberg, A, Delco, F;2002
Anton;vok2012.pdf;cost-effectiveness of adding vaccination with the AS04-adjuvanted human papillomavirus 16/18 vaccine to cervical cancer screening in Hungary;Voko, Zoltan  Nagyjanosi, Laszlo  Kalo, Zoltan;2012
Noneg;ahern2014.pdf;cost-effectiveness of alternative strategies for integrating mri into breast cancer screening for women at high risk;Ahern CH1, Shih YC2, Dong W3, Parmigiani G4, Shen Y3.;2014
Noneg;cronin2013.pdf;cost-effectiveness of an advance notification letter to increase colorectal cancer screening;Cronin, Paula, Goodall, Stephen, Lockett, Trevor, O'Keefe, Christine M., Norman, Richard, Church, Jody;2013
Anton;czw182.pdf;cost-effectiveness of an hpv self-collection campaign in uganda comparing models for delivery of cervical cancer screening in a low-income setting;Campos, Nicole G.  Tsu, Vivien  Jeronimo, Jose  Njama-Meya, Denise  Mvundura, Mercy  Kim, Jane J.;2017
Anton;pataky2014 (1).pdf;cost-effectiveness of annual versus biennial screening mammography for women with high mammographic breast density;Pataky, Reka  Ismail, Zahra  Coldman, Andrew J.  Elwood, Mark  Gelmon, Karen  Hedden, Lindsay  Hislop, Greg  Kan, Lisa  McCoy, Bonnie  Olivotto, Ivo A.  Peacock, Stuart;2014
Noneg;gocgun2015.pdf;cost-effectiveness of breast cancer screening policies using simulation;Gocgun Y1, Banjevic D2, Taghipour S3, Montgomery N2, Harvey BJ4, Jardine AK2, Miller AB4.;2015
Noneg;10.1097@grf.0b013e3182823797.pdf;cost-effectiveness of cervical cancer prevention;;2013
Noneg;berkhof2013.pdf;cost-effectiveness of cervical cancer prevention in central and eastern europe and central asia;Vaccine. 2013 Dec 31.31 Suppl 7:H71-9. doi: 10.1016/j.vaccine.2013.04.086.;2005
q12;zimmermann2017.pdf;cost-effectiveness of cervical cancer screening and preventative cryotherapy at anHIV treatment clinic in Kenya;Zimmermann, Marita R., Vodicka, Elisabeth, Babigumira, Joseph B., Okech, Timothy, Mugo, Nelly, Sakr, Samah, Garrison, Louis P., Chung, Michael H.;2017
Anton;10.1093@jnci@94.3.193.pdf;cost-effectiveness of cervical cancer screening comparison of screening policies;van den Akker-van Marle, ME  van Ballegooijen, M  van Oortmarssen, GJ  Boer, R  Habbema, JDF;2002
Anton;burger2012.pdf;cost-effectiveness of cervical cancer screening with primary human papillomavirus testing in norway;Burger, E. A.  Ortendahl, J. D.  Sy, S.  Kristiansen, I. S.  Kim, J. J.;2012
Anton;ladabaum2010.pdf;cost-effectiveness of colorectal cancer screening in high-risk spanish patients use of a validated model to inform public policy;Ladabaum, Uri  Ferrandez, Angel  Lanas, Angel;2010
Noneg;melnitchouk2018.pdf;cost-effectiveness of colorectal cancer screening in Ukraine;Melnitchouk, Nelya, Soeteman, Djora I., Davids, Jennifer S., Fields, Adam, Cohen, Joshua, Noubary, Farzad, Lukashenko, Andrey, Kolesnik, Olena O., Freund, Karen M.;2018
Anton;romagnuolo2007.pdf;cost-effectiveness of Colorectal Cancer Screening With Computed Tomography Colonography The Impact of Not Reporting Diminutive Lesions;Pickhardt, Perry J.  Hassan, Cesare  Laghi, Andrea  Zullo, Angelo  Kim, David H.  Morini, Sergio;2007
FromReview;knudsen2010.pdf;cost-effectiveness of computed tomographic colonography screening for colorectal cancer in the medicare population;Knudsen, Amy B.  Lansdorp-Vogelaar, Iris  Rutter, Carolyn M.  Savarino, James E.  van Ballegooijen, Marjolein  Kuntz, Karen M.  Zauber, Ann G.;2010
Anton;hanly2012.pdf;cost-effectiveness of computed tomography colonography in colorectal cancer screening a systematic review;Hanly, Paul  Skally, Mairead  Fenlon, Helen  Sharp, Linda;2012
Noneg;mcmahon2011.pdf;cost-effectiveness of computed tomography screening for lung cancer in the united states;McMahon, Pamela M., Kong, Chung Yin, Bouzan, Colleen, Weinstein, Milton C., Cipriano, Lauren E., Tramontano, Angela C., Johnson, Bruce E., Weeks, Jane C., Gazelle, G. Scott;2011
FromReview;a05v50n4.pdf;cost-effectiveness of conventional cytology and hpv dna testing for cervical cancer screening in colombia;Andres-Gamboa, Oscar  Chicaiza, Liliana  Garcia-Molina, Mario  Diaz, Jorge  Gonzalez, Mauricio  Murillo, Raul  Ballesteros, Monica  Sanchez, Ricardo;2008
Noneg;lee2010.pdf;cost-effectiveness of ct colonography for uk nhs colorectal cancer screening of asymptomatic adults aged 60-69 years;;2010
Noneg;nahvijou2016.pdf;cost-effectiveness of different cervical screening strategies in islamic republic of iran a middle-income country with a low incidence rate of cervical cancer;Nahvijou A1, Daroudi R2, Tahmasebi M1, Amouzegar Hashemi F1, Rezaei Hemami M3, Akbari Sari A2, Barati Marenani A4, Zendehdel K5.;2016
Anton;groenewoud2006.pdf;cost-effectiveness of different reading and referral strategies in mammography screening in the netherlands;Groenewoud, J. H.  Otten, J. D. M.  Fracheboud, J.  Draisma, G.  van Ineveld, B. M.  Holland, R.  Verbeek, A. L. M.  de Koning, H. J.;2007
Noneg;sankatsing2015.pdf;cost-effectiveness of digital mammography screening before the age of 50 in the netherlands;Sankatsing VD1, Heijnsdijk EA1, van Luijt PA1, van Ravesteyn NT1, Fracheboud J1, de Koning HJ1.;2015
FromReview;glick1998.pdf;cost-effectiveness of Double-Contrast Barium Enema in Screening for Colorectal Cancer;;
Noneg;carles2011.pdf;cost-effectiveness of early detection of breast cancer in catalonia spain;Carles M1, Vilaprinyo E, Cots F, Gregori A, Pla R, Rom?n R, Sala M, Maci? F, Castells X, Rue M.;2011
Noneg;ouakrim2014.pdf;cost-effectiveness of family history-based colorectal cancer screening in Australia;Ouakrim, Driss A., Boussioutas, Alex, Lockett, Trevor, Hopper, John L., Jenkins, Mark A.;2014
Anton;jit2014.pdf;cost-effectiveness of female human papillomavirus vaccination in 179 countries a prime modelling study;Jit M1, Brisson M2, Portnoy A3, Hutubessy R4.;2014
Anton;vijayaraghavan2009.pdf;cost-effectiveness of high-risk hpv dna testing for cervical cancer screening in south africa;Vijayaraghavan, Arthi  Efrusy, Molly  Lindeque, Gerhard  Dreyer, Greta  Santas, Christopher;2009
Anton;10.2307@41995445.pdf;cost-effectiveness of high-risk human papillomavirus testing for cervical cancer screening in quebec canada;Vijayaraghavan, Arthi  Efrusy, Molly B.  Mayrand, Marie-Helene  Santas, Christopher C.  Goggin, Patricia;2010
Anton;ekwunife2017.pdf;cost-effectiveness of human papilloma virus hpv vaccination in nigeria a decision analysis using pragmatic parameter estimates for cost and programme coverage;Ekwunife O.I., Lhachimi S.K.;2017
q12;diaz2010.pdf;cost-effectiveness of human papillomavirus vaccination and screening in spain;Diaz M1, de Sanjose S, Ortendahl J, O'Shea M, Goldie SJ, Bosch FX, Kim JJ.;2010
q12;thiry2009.pdf;cost-effectiveness of human papillomavirus vaccination in belgium do not forget about cervical cancer screening;Thiry N1, De Laet C, Hulstaert F, Neyt M, Huybrechts M, Cleemput I.;2009
Anton;chesson2008.pdf;cost-effectiveness of Human Papillomavirus Vaccination inthe United States;Chesson HW1, Ekwueme DU, Saraiya M, Markowitz LE.;2008
Anton;huh2014.pdf;cost-effectiveness of human papillomavirus-16/18 genotyping in cervical cancer screening;Huh, Warner K.  Williams, Erin  Huang, Joice  Bramley, Tommy  Poulios, Nick;2015
Noneg;sharma2016.pdf;cost-effectiveness of increasing cervical cancer screening coverage in the middle east an example from lebanon;Sharma M1, Seoud M2, Kim JJ3.;2017
Noneg;wong2007.pdf;cost-effectiveness of mammography screening for chinese women;Wong IO1, Kuntz KM, Cowling BJ, Lam CL, Leung GM.;2007
Anton;moore2009.pdf;cost-effectiveness of mri compared to mammography for breast cancer screening in a high risk population;Moore, Susan G.  Shenoy, Pareen J.  Fanucchi, Laura  Tumeh, John W.  Flowers, Christopher R.;2009
FromReview;10.1016@j.ejca.2008.09.015.pdf;cost-effectiveness of opportunistic versus organised mammography screening in switzerland;de Gelder, Rianne  Bulliard, Jean-Luc  de Wolf, Chris  Fracheboud, Jacques  Draisma, Gerrit  Schopper, Doris  de Koning, Harry J.;2009
FromReview;kim2004.pdf;cost-effectiveness of organized versus opportunistic cervical cytology screening in hong kong;Kim, JJ  Leung, GM  Woo, PPS  Goldie, SJ;2004
FromReview;sroczynski2011.pdf;cost-effectiveness of primary hpv screening for cervical cancer in germany - a decision analysis;Sroczynski G., Schnell-Inderst P., Muhlberger N., Lang K., Aidelsburger P., Wasem J., Mittendorf T., Engel J., Hillemanns P., Petry K.U., Kramer A., Siebert U.;2011
Anton;torvinen2010.pdf;cost-effectiveness of prophylactic hpv 1618 vaccination in finland results from a modelling exercise;Torvinen S1, Nieminen P, Lehtinen M, Paavonen J, Demarteau N, Hahl J.;2010
Anton;rogoza2009.pdf;cost-effectiveness of prophylactic vaccination against human papillomavirus 1618 for the prevention of cervical cancer adaptation of an existing cohort model to the situation in the netherlands;Rogoza RM1, Westra TA, Ferko N, Tamminga JJ, Drummond MF, Daemen T, Wilschut JC, Postma MJ.;2009
Noneg;lejeune2010.pdf;cost-effectiveness of screening for colorectal cancer in france using a guaiac test versus an immunochemical test;Lejeune C1, Dancourt V, Arveux P, Bonithon-Kopp C, Faivre J.;2010
Noneg;provenzale2002.pdf;cost-effectiveness of screening the average-risk population for colorectal cancer;Gastrointest Endosc Clin N Am. 2002 Jan.12(1):93-109.;3665
Noneg;376.pdf;cost-effectiveness of shortening screening interval or extending age range of nhs breast screening programme computer simulation study;BMJ. 1998 Aug 8.317(7155):376-9.;2522
Anton;simms2016.pdf;cost-effectiveness of the next generation nonavalent human papillomavirus vaccine in the context of primary human papillomavirus screening in australia a comparative modelling analysis;Simms, Kate T.  Laprise, Jean-Francois  Smith, Megan A.  Lew, Jie-Bin  Caruana, Michael  Brisson, Marc  Canfell, Karen;2016
FromReview;pharoah2013.pdf;cost-effectiveness of the NHS breast screening programme: life table model;;
Anton;10.1002@ijc.30513.pdf;cost-effectiveness of the Norwegian Breast cancer screening program.;van Luijt, P. A.  Heijnsdijk, E. A. M.  de Koning, H. J.;2017
Anton;luttjeboer2013.pdf;cost-effectiveness of the prophylactic hpv vaccine an application to the netherlands taking non-cervical cancers and cross-protection into account;Luttjeboer J1, Westra TA, Wilschut JC, Nijman HW, Daemen T, Postma MJ.;2013
Noneg;ijcp-09-01-5443.pdf;cost-effectiveness of three rounds of mammography breast cancer screening in iranian women;Haghighat, Shahpar, Akbari, Mohammad Esmaeil, Yavari, Parvin, Javanbakht, Mehdi, Ghaffari, Shahram;2016
Noneg;nihms307273.pdf;costs and cost-effectiveness of full implementation of a biennial faecal occult blood test screening program for bowel cancer in australia;Med J Aust. 2011 Feb 21.194(4):180-5.;1993
Noneg;zelle2012.pdf;costs effects and cost-effectiveness of breast cancer control in ghana;Zelle SG1, Nyarko KM, Bosu WK, Aikins M, Ni??ns LM, Lauer JA, Sepulveda CR, Hontelez JA, Baltussen R.;2012
Anton;quentin2011.pdf;costs of cervical cancer screening and treatment using visual inspection with acetic acid via and cryotherapy in ghana the importance of scale;Quentin W1, Adu-Sarkodie Y, Terris-Prestholt F, Legood R, Opoku BK, Mayaud P.;2011
Noneg;whynes2003.pdf;costs of flexible sigmoidoscopy screening for colorectal cancer in the united kingdom;Whynes, DK, Frew, EJ, Edwards, R, Atkin, WS;2003
Noneg;karnon2008.pdf;cost-utility analysis of screening high-risk groups for anal cancer;Karnon, Jonathan, Jones, Roy, Czoski-Murray, Carolyn, Srnith, Kevin J.;2008
FromReview;ness2000.pdf;Cost-Utility of One-Time Colonoscopic Screening for Colorectal Cancer at Various Ages;;
Anton;silvaillanes2018 (1).pdf;critical analysis of markov models used for the economic evaluation of colorectal cancer screening a systematic review;Silva-Illanes N1, Espinoza M2.;2018
FromReview;cmaj_160_1_49.pdf;Current and projected annual direct costs of screening asymptomatic men for prostate cancer using prostate-specific antigen;;
Noneg;frame1998.pdf;determinants of cancer screening frequency the example of screening for cervical cancer;;1998
Noneg;roberts2007.pdf;development of a simulation model of colorectal cancer;Roberts, Stephen, Wang, Lijun, Klein, Robert, Ness, Reid, Dittus, Robert;2008
Noneg;10.1016@j.ypmed.2011.06.009.pdf;digital mammography screening weighing reduced mortality against increased overdiagnosis;de Gelder, Rianne, Fracheboud, Jacques, Heijnsdijk, Eveline A. M., den Heeten, Gerard, Verbeek, Andre L. M., Broeders, Mireille J. M., Draisma, Gerrit, de Koning, Harry J.;2011
Anton;boer2004.pdf;Diversity of model approaches for breast cancer screening: a review of model assumptions by The Cancer Intervention and Surveillance Network(CISNET) Breast Cancer Groups;Boer R1, Plevritis S, Clarke L.;2004
Noneg;1328.full.pdf;do men and women need to be screened differently with fecal immunochemical testing a cost-effectiveness analysis;van der Meulen, Miriam P., Kapidzic, Atija, van Leerdam, Monique E., van der Steen, Alex, Kuipers, Ernst J., Spaander, Manon C. W., de Koning, Harry J., Hol, Lieke, Lansdorp-Vogelaar, Iris;2017
Noneg;armaroli2008.pdf;do women or50 years of age need as much screening as women 50 years after they have had negative screening results;Armaroli P1, Gallo F, Bellomi A, Ciatto S, Consonni D, Davi D, Giorgi-Rossi P, Iossa A, Mancini E, Naldoni C, Polla E, Ronco G, Serafini M, Vergini V, Zanier L, Zappa M, Segnan N.;2008
FromReview;beer2014.pdf;Does the HPV vaccination programme have implications for cervical screening programmes in the UK?;;
q12;birnbaum2018.pdf;early detection and treatment strategies for breast cancer in low-income and upper middle-income countries a modelling study;Birnbaum, Jeanette K., Duggan, Catherine, Anderson, Benjamin O., Etzioni, Ruth;2018
Noneg;philips2001.pdf;early withdrawal from cervical cancer screening the question of cost-effectiveness;Philips, Z, Whynes, DK;2001
Noneg;10.1002@sici1099-1751199901@0314@157@@aid-hpm5313.0.co2-u.pdf;economic analysis of outreach assessment clinics in breast screening programmes;;1999
FromReview;nghiem2015.pdf;Economic evaluation of DNA ploidy analysis vs liquid-based cytology for cervical screening;;
Anton;brisson2009.pdf;economic evaluation of human papillomavirus vaccination in developed countries;Brisson M1, Van de Velde N, Boily MC.;2009
q12;praditsitthikorn2011.pdf;Economic Evaluation of Policy Options for Prevention and Control of Cervical Cancer in Thailand;Praditsitthikorn N1, Teerawattananon Y, Tantivess S, Limwattananon S, Riewpaiboon A, Chichareon S, Ieumwananonthachai N, Tangcharoensathien V.;2011
FromReview;holmberg1998.pdf;Economic evaluation of screening for prostate cancer: a randomized population based programme during a 10-year period in Sweden;;
Anton;vanni2010.pdf;economic evaluation of strategies for managing women with equivocal cytological results in brazil;Vanni T1, Legood R, Franco EL, Villa LL, Luz PM, Schwartsmann G.;2011
Noneg;arrospide2016.pdf;economic evaluation of the breast cancer screening programme in the basque country retrospective cost-effectiveness and budget impact analysis;Arrospide A1,2,3, Rue M4,5, van Ravesteyn NT6, Comas M4,7, Soto-Gordoa M8, Sarriugarte G9, Mar J8,10,4,11.;2016
Noneg;medi-95-e3762.pdf;economic evaluation study cheer-compliant cost-effectiveness analysis of ras screening for treatment of metastatic colorectal cancer based on the calgb 80405 trial;Zhou, Jing, Zhao, Rongce, Wen, Feng, Zhang, Pengfei, Tang, Ruilei, Chen, Hongdou, Zhang, Jian, Li, Qiu;2016
Anton;vanni2012.pdf;economic modelling assessment of the hpv quadrivalent vaccine in brazil a dynamic individual-based approach;Vanni T1, Luz PM, Foss A, Mesa-Frias M, Legood R.;2012
Noneg;molins2009.pdf;effect of participation on the cumulative risk of false-positive recall in a breast cancer screening programme;Research Support, Non-U.S. Gov't,Aged,Breast Neoplasms/diagnosis*,Cohort Studies,Early Detection of Cancer/methods,Early Detection of Cancer/statistics & numerical data,False Positive Reactions*,Female,Humans,Mammography/psychology,Mammography/statistics & numerical data*,Mass Screening/methods*,Middle Aged,Proportional Hazards Models,Risk Factors;1973
q12;158.full.pdf;effect of time to diagnostic testing for breast cervical and colorectal cancer screening abnormalities on screening efficacy a modeling study;Rutter, Carolyn M., Kim, Jane J., Meester, Reinier G. S., Sprague, Brian L., Burger, Emily A., Zauber, Ann G., Ergun, Mehmet Ali, Campos, Nicole G., Doubeni, Chyke A., Trentham-Dietz, Amy, Sy, Stephen, Alagoz, Oguzhan, Stout, Natasha, Lansdorp-Vogelaar, Iris, Corley, Douglas A., Tosteson, Anna N. A.;2018
Noneg;agorastos2010.pdf;effect of type-specific human papillomavirus incidence on screening performance and cost;;2010
Anton;liu2016.pdf;Effect of vaccination age on cost-effectiveness of human papillomavirus vaccination against cervical cancer in China;Liu YJ1,2, Zhang Q1, Hu SY3, Zhao FH1.;2016
;effective_screening_programmes.pdf;Effective screening programmes for cervical cancer in low- and middle-income developing countries;;
Noneg;rue2009.pdf;effectiveness of early detection on breast cancer mortality reduction in catalonia spain;Rue M1, Vilaprinyo E, Lee S, Martinez-Alonso M, Carles MD, Marcos-Gragera R, Pla R, Espinas JA.;2009
Noneg;mandelblatt2009.pdf;effects of mammography screening under different screening schedules model estimates of potential benefits and harms;Mandelblatt JS1, Cronin KA, Bailey S, Berry DA, de Koning HJ, Draisma G, Huang H, Lee SJ, Munsell M, Plevritis SK, Ravdin P, Schechter CB, Sigal B, Stoto MA, Stout NK, van Ravesteyn NT, Venier J, Zelen M, Feuer EJ. Breast Cancer Working Group of the Cancer Intervention and Surveillance Modeling Network.;2009
FromReview;munoz2014.pdf;Effects of Screening and Systemic Adjuvant Therapy on ER-Specific US Breast Cancer Mortality;;
Noneg;koong2007.pdf;efficacy and cost-effectiveness of nationwide cervical cancer screening in taiwan;J Med Screen. 2006.13 Suppl 1:S44-7.;1995
Noneg;hassan2015.pdf;efficacy and cost-effectiveness of screening colonoscopy according to the adenoma detection rate;Hassan C., Rex D.K., Zullo A., Kaminski M.F.;2015
Noneg;lai1998.pdf;efficacy of breast-cancer screening for female relatives of breast-cancer-index cases taiwan multicentre cancer screening tamcas;Lai MS1, Yen MF, Kuo HS, Koong SL, Chen TH, Duffy SW.;1998
Noneg;llewellyn2006.pdf;endoscopic colorectal cancer screening a cost-saving analysis;Loeve, F, Brown, ML, Boer, R, van Ballegooijen, M, van Oortmarssen, GJ, Habbema, JDF;2000
FromReview;rodrguezmoranta2008.pdf;Endoscopic requirements of colorectal cancer screening programs in average-risk population. Estimation according to a Markov model;;
q12;hoerger2011.pdf;Estimated Effects of the National Breast and Cervical Cancer Early Detection Program on Breast Cancer Mortality;Hoerger TJ1, Ekwueme DU, Miller JW, Uzunangelov V, Hall IJ, Segel J, Royalty J, Gardner JG, Smith JL, Li C.;2011
Anton;gunsoy2014.pdf;estimating breast cancer mortality reduction and overdiagnosis due to screening for different strategies in the united kingdom;Gunsoy, N. B.  Garcia-Closas, M.  Moss, S. M.;2014
Anton;munoz2018.pdf;estimating breast cancer survival by molecular subtype in the absence of screening and adjuvant treatment;Munoz, Diego F.  Plevritis, Sylvia K.;2018
Noneg;chen2010.pdf;estimating key parameters in periodic breast cancer screening-application to the canadian national breast screening study data;;2010
Anton;zhang2016.pdf;estimating long-term clinical effectiveness and cost-effectiveness of hpv 1618 vaccine in china;Zhang Q1, Liu YJ1,2, Hu SY1, Zhao FH3.;2016
Anton;weedonfekjaer2008.pdf;estimating mean sojourn time and screening sensitivity using questionnaire data on time since previous screening;Weedon-Fekjaer H1, Lindqvist BH, Vatten LJ, Aalen OO, Tretli S.;2008
Noneg;weedonfekjaer2010.pdf;Estimating screening test sensitivity and tumour progression using tumour size and time since previous screening;Weedon-Fekjaer H1, Tretli S, Aalen OO.;2010
FromReview;prevost1998.pdf;Estimating Sensitivity and Sojourn Time in Screening for Colorectal Cancer A Comparison of Statistical Approaches;;
Noneg;mvundura2014.pdf;estimating the costs of cervical cancer screening in high-burden sub-saharan african countries;Mvundura M1, Tsu V2.;2014
Noneg;bending2010.pdf;estimating the direct costs of bowel cancer services provided by the national health service in england;Bending M.W., Trueman P., Lowson K.V., Pilgrim H., Tappenden P., Chilcott J., Tappenden J.;2010
Anton;carlsson2016.pdf;estimating the harms and benefits of prostate cancer screening as used in common practice versus recommended good practice a microsimulation screening analysis;Carlsson, Sigrid V.  de Carvalho, Tiago M.  Roobol, Monique J.  Hugosson, Jonas  Auvinen, Anssi  Kwiatkowski, Maciej  Villers, Arnauld  Zappa, Marco  Nelen, Vera  Paez, Alvaro  Eastham, James A.  Lilja, Hans  de Koning, Harry J.  Vickers, Andrew J.  Heijnsdijk, Eveline A. M.;2016
Anton;10.1002@ijc.29976.pdf;estimating the individual benefit of immediate treatment or active surveillance for prostate cancer after screen-detection in older 65 men;de Carvalho, Tiago M.  Heijnsdijk, Eveline A. M.  de Koning, Harry J.;2016
Anton;yen2009.pdf;estimating the long-term clinical impact of cervical cancer vaccination in taiwan;Yen MS1, You SL, Ferko N, Debicki D, Chen YC, Chou CY.;2009
Anton;kohli2006.pdf;estimating the long-term impact of a prophylactic human papillomavirus 1618 vaccine on the burden of cervical cancer in the uk;Kohli M1, Ferko N, Martin A, Franco EL, Jenkins D, Gallivan S, Sherlaw-Johnson C, Drummond M.;2007
FromReview;pinsky2001.pdf;Estimation and Prediction for Cancer Screening Models Using Deconvolution and Smoothing;;
Noneg;chang2007.pdf;estimation and prediction system for multi-state disease process application to analysis of organized screening regime;Chang, Chi-Ming, Lin, Wen-Chou, Kuo, Hsu-Sung, Yen, Ming-Fang, Chen, Tony Hsiu-Hsi;2007
FromReview;chien2008.pdf;estimation of mean sojourn time for lung cancer by chest x-ray screening with a bayesian approach;Chien, Chun-Ru  Lai, Mei-Shu  Chen, Tony Hsiu-Hsi;2008
Noneg;wu2010.pdf;estimation of natural history parameters of breast cancer based on non-randomized organized screening data subsidiary analysis of effects of inter-screening interval sensitivity and attendance rate on reduction of advanced cancer;Breast Cancer Res Treat. 2010 Jul.122(2):553-66. doi: 10.1007/s10549-009-0701-x. Epub 2010 Jan 7.;1988
Anton;kim2012.pdf;estimation of sensitivity depending on sojourn time and time spent in preclinical state;Kim S., Wu D.;2012
Anton;westvik2018.pdf;evaluating different breast tumor progression models using screening data;Westvik, Asbjorn Schumacher  Weedon-Fekjaer, Harald  Maehlen, Jan  Liestol, Knut;2018
Noneg;sheehan2017.pdf;evaluating lung cancer screening in china implications for eligibility criteria design from a microsimulation modeling approach;Sheehan DF1, Criss SD1, Gazelle GS1,2,3, Pandharipande PV1,2, Kong CY1,2.;2017
Noneg;baker1998.pdf;evaluating the age to begin periodic breast cancer screening using data from a few regularly scheduled screenings;;1998
Anton;han2017 (1).pdf;evaluating the impact of varied compliance to lung cancer screening recommendations using a microsimulation model;Han, Summer S.  Erdogan, S. Ayca  Toumazis, Iakovos  Leung, Ann  Plevritis, Sylvia K.;2017
Noneg;tramontano2016.pdf;evaluating the impacts of screening and smoking cessation programmes on lung cancer in a high-burden region of the usa a simulation modelling study;Tramontano AC1, Sheehan DF1, McMahon PM2, Dowling EC1, Holford TR3, Ryczak K4, Lesko SM4, Levy DT5, Kong CY2.;2016
Noneg;chen1998.pdf;evaluation by markov chain models of a non-randomised breast cancer screening programme in women aged under 50 years in sweden;;1998
Anton;gray2017.pdf;evaluation of a stratified national breast screening program in the united kingdom an early model-based cost-effectiveness analysis;Gray, Ewan  Donten, Anna  Karssemeijer, Nico  van Gils, Carla  Evans, D. Gareth  Astley, Sue  Payne, Katherine;2017
Noneg;2043.full.pdf;evaluation of breast cancer risk assessment techniques a cost-effectiveness analysis;;2004
Anton;berkhof2006.pdf;evaluation of cervical screening strategies with adjunct high-risk human papillomavirus testing for women with borderline or mild dyskaryosis;Berkhof, J  de Bruijne, MC  Zielinski, GD  Bulkmans, NWJ  Rozendaal, L  Snijders, PJF  Verheijen, RHM  Meijer, CJLM;2006
Noneg;arrospide2015.pdf;evaluation of health benefits and harms of the breast cancer screening programme in the basque country using discrete event simulation;Arrospide A1,2,3, Rue M4,5, van Ravesteyn NT6, Comas M7,8, Larra??aga N9,10, Sarriugarte G11, Mar J12,13,14,15.;2015
Noneg;lew2018.pdf;Evaluation of the benefits, harms and cost-effectiveness of potential alternatives to iFOBT testing for colorectal cancer screening in Australia;Lew, Jie-Bin, St John, D. James B., Macrae, Finlay A., Emery, Jon D., Ee, Hooi C., Jenkins, Mark A., He, Emily, Grogan, Paul, Caruana, Michael, Sarfati, Diana, Greuter, Marjolein J. E., Coupe, Veerle M. H., Canfell, Karen;2018
Noneg;idigoras2018.pdf;evaluation of the colorectal cancer screening programme in the basque country spain and its effectiveness based on the miscan-colon model;Idigoras, I., Arrospide, A., Portillo, I., Arana-Arri, E., Martinez-Indart, L., Mar, J., de Koning, H. J., Lastra, R., Soto-Gordoa, M., van der Meulen, M., Lansdorp-Vogelaar, I.;2017
q12;10.1.1.552.8587.pdf;evolution of multiple disease screening in keelung a model for community involvement in health interventions;Wang PE1, Wang TT, Chiu YH, Yen AM, Chen TH.;2006
Noneg;oncotarget-07-48168.pdf;expected long-term impact of screening endoscopy on colorectal cancer incidence a modelling study;Brenner, Hermann, Kretschmann, Jens, Stock, Christian, Hoffmeister, Michael;2016
Noneg;brenner2015.pdf;expected long-term impact of the german screening colonoscopy programme on colorectal cancer prevention analyses based on 4407971 screening colonoscopies;Brenner, Hermann, Altenhofen, Lutz, Stock, Christian, Hoffmeister, Michael;2015
Noneg;lew2012.pdf;Expenditure and resource utilisation for cervical screening in Australia;BMC Health Serv Res. 2012 Dec 5.12:446. doi: 10.1186/1472-6963-12-446.;2007
Noneg;duffy2010.pdf;Modelling the likely effect of the increase of the upper age limit from 70 to 73 for breast screening in the UK National Programme;Duffy SW1, Sasieni P, Olsen AH, Cafferty FH.;2010
Noneg;duarte2017.pdf;Exploring risk factors in breast cancer screening program data using structured geoadditive models with high order interaction;Duarte, Elisa, de Sousa, Bruno, Cadarso-Suarez, Carmen, Kneib, Thomas, Rodrigues, Vitor;2017
Anton;kim2008.pdf;Exploring the cost-effectiveness of HPV vaccination in Vietnam: Insights for evidence-based cervical cancer prevention policy;Kim JJ1, Kobus KE, Diaz M, O'Shea M, Van Minh H, Goldie SJ.;2008
Anton;shi2011.pdf;exploring the uncertainties of early detection results model-based interpretation of mayo lung project;Shi, Lu  Tian, Haijun  McCarthy, William J.  Berman, Barbara  Wu, Shinyi  Boer, Rob;2011
Noneg;russell2011.pdf;exploring the unknown and the unknowable with simulation models;Editorial,Comment,Bayes Theorem*,Colorectal Neoplasms/diagnosis*,Colorectal Neoplasms/epidemiology*,Decision Support Techniques*,Disease Progression*,Humans,Male,Mass Screening/standards*,Models, Theoretical*,Prostatic Neoplasms/diagnosis*,Uncertainty*;2175
Noneg;whynes1998.pdf;faecal occult blood screening for colorectal cancer is it cost-effective;;1998
Noneg;fisher2010.pdf;faecal occult blood testing in areas of high incidence and mortality the effect of screening the population aged 50 to 59;Fisher R1, Rooney PS.;2011
Noneg;sharma2008.pdf;fecal occult blood testing best option for colorectal cancer screening in asia;News,Aged,Asia, Southeastern/epidemiology,Colonoscopy/economics,Colorectal Neoplasms/diagnosis*,Colorectal Neoplasms/economics,Colorectal Neoplasms/epidemiology,Colorectal Neoplasms/prevention & control*,Cost-Benefit Analysis,Far East/epidemiology,Humans,Incidence,Markov Chains,Mass Screening/economics*,Mass Screening/methods*,Middle Aged,Occult Blood*,Patient Compliance,Practice Guidelines as Topic,Sigmoidoscopy/economics;1866
q12;hkm1512sp6p9.pdf;generalised cost-effectiveness analysis for breast cancer prevention and care in hong kong chinese;Research Support, Non-U.S. Gov't,Adult,Aged,Antineoplastic Protocols,Asian Continental Ancestry Group,Breast Neoplasms/prevention & control*,Breast Neoplasms/therapy,Chemotherapy, Adjuvant/economics,Cost-Benefit Analysis/methods*,Early Detection of Cancer/economics*,Early Detection of Cancer/methods,Female,Health Care Costs*,Hong Kong,Humans,Immunotherapy/economics,Mammography/economics,Markov Chains,Middle Aged,Quality-Adjusted Life Years,Radiotherapy, Adjuvant/economics;2664
Anton;draisma2006.pdf;gleason score age and screening modeling dedifferentiation in prostate cancer;Draisma, Gerrit  Postma, Renske  Schroder, Fritz H.  van der Kwast, Theo H.  de Koning, Harry J.;2006
FromReview;kearns2014.pdf;Guaiac faecal occult blood test performance at initial and repeat screens in the English Bowel Cancer Screening Programme;;
Noneg;goede2017.pdf;harms benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening;PLoS One. 2017 Mar 15.12(3):e0172864. doi: 10.1371/journal.pone.0172864. eCollection 2017.;1000
Anton;mennini2009.pdf;health and economic impact associated with a quadrivalent hpv vaccine in italy;Mennini FS1, Giorgi Rossi P, Palazzo F, Largeron N.;2009
Noneg;krahn2013.pdf;health care costs for state transition models in prostate cancer;Krahn M.D., Bremner K.E., Zagorski B., Alibhai S.M.H., Chen W., Tomlinson G., Mitsakakis N., Naglie G.;2014
Anton;gomez2014.pdf;health economic analysis of human papillomavirus vaccines in women of chile perspective of the health care payer using a markov model;Gomez JA, Lepetic A1, Demarteau N.;2014
Anton;vanagas2012.pdf;healthcare spending in the case of a hpv1618 population-wide vaccination programme;Vanagas G1, Padaiga Z.;2012
Noneg;howard2005.pdf;High participation rates are not necessary for cost-effective colorectal cancer screening;Howard K1, Salkeld G, Irwig L, Adelstein BA.;2005
q12;wever2011.pdf;how does early detection by screening affect disease progression modeling estimated benefits in prostate cancer screening;Wever EM1, Draisma G1, Heijnsdijk EA1, de Koning HJ1.;2011
Anton;sasieni2009.pdf;how many cervical cancers are prevented by treatment of screen-detected disease in young women;Sasieni P., Castanon A., Parkin D.M.;2009
Noneg;wilschut2011.pdf;how much colonoscopy screening should be recommended to individuals with various degrees of family history of colorectal cancer;Wilschut, Janneke A., Steyerberg, Ewout W., van Leerdam, Monique E., Lansdorp-Vogelaar, Iris, Habbema, J. Dik F., van Ballegooijen, Marjolein;2011
Anton;nihms458845.pdf;how should individuals with a false-positive fecal occult blood test for colorectal cancer be managed a decision analysis;Haug U1, Knudsen AB, Kuntz KM.;2012
FromReview;coup2009.pdf;How to screen for cervical cancer after HPV16/18 vaccination in The Netherlands;;
Anton;velentzis2017.pdf;How will transitioning from cytology to HPV testing change the balance between the benefits and harms of cervical cancer screening? Estimates of the impact on cervical cancer, treatment rates and adverse obstetric outcomes in Australia, a high vaccination coverage country;Velentzis, Louiza S.  Caruana, Michael  Simms, Kate T.  Lew, Jie-Bin  Shi, Ju-Fang  Saville, Marion  Smith, Megan A.  Lord, Sarah J.  Tan, Jeffrey  Bateson, Deborah  Quinn, Michael  Canfell, Karen;2017
Noneg;flores2010.pdf;hpv testing for cervical cancer screening appears more cost-effective than papanicolau cytology in mexico;Flores Y.N., Bishai D.M., Lorincz A., Shah K.V., Lazcano-Ponce E., Hernandez M., Granados-Garcia V., Perez R., Salmeron J.;2011
Anton;crowcroft2012.pdf;Human papilloma virus vaccination programs reduce health inequity in most scenarios: a simulation study;Crowcroft N.S., Hamid J.S., Deeks S.L., Frank J.;2012
Noneg;kulasingam2009.pdf;Human papillomavirus testing with Pap triage for cervical cancer prevention in Canada: a cost-effectiveness analysis;;2009
Anton;jit2011.pdf;human papillomavirus vaccine introduction in low-income and middle-income countries guidance on the use of cost-effectiveness models;Jit M1, Demarteau N, Elbasha E, Ginsberg G, Kim J, Praditsitthikorn N, Sinanovic E, Hutubessy R.;2011
q12;janes2005.pdf;identifying target populations for screening or not screening using logic regression;Janes H., Pepe M., Kooperberg C., Newcomb P.;2005
Anton;meester2017.pdf;Impact of Adenoma Detection on the Benefit of Faecal Testing versus Colonoscopy for Colorectal Cancer;Meester, Reinier G. S.  Doubeni, Chyke A.  Zauber, Ann G.  van Ballegooijen, Marjolein  Corley, Douglas A.  Lansdorp-Vogelaar, Iris;2017
Anton;jacklyn2017.pdf;Impact of extending screening mammography to older women: information to support informed choices;Jacklyn, Gemma  Howard, Kirsten  Irwig, Les  Houssami, Nehmat  Hersch, Jolyn  Barratt, Alexandra;2017
Noneg;10.5694mja15.00912.pdf;impact of hpv sample self-collection for underscreened women in the renewed cervical screening program;Med J Aust. 2016 Mar 21.204(5):1941e-7.;2017
Anton;montz2001.pdf;impact of increasing papanicolaou test sensitivity and compliance a modeled cost and outcomes analysis;Montz FJ1, Farber FL, Bristow RE, Cornelison T.;2001
FromReview;etzioni2008.pdf;impact of psa screening on the incidence of advanced stage prostate cancer in the united states a surveillance modeling approach;Etzioni, Ruth  Gulati, Roman  Falcon, Seth  Penson, David F.;2008
Noneg;blanch2014.pdf;impact of risk factors on different interval cancer subtypes in a population-based breast cancer screening programme;Blanch J1, Sala M2, Ib???ez J3, Domingo L4, Fernandez B5, Otegi A6, Barata T7, Zubizarreta R5, Ferrer J8, Castells X2, Ru?? M9, Salas D3. INCA Study Group.;2014
Noneg;loeve2001.pdf;impact of systematic false-negative test results on the performance of faecal occult blood screening;Eur J Cancer. 2001 May.37(7):912-7.;1000
Anton;ekwueme2014.pdf;Impact of the National Breast and Cervical Cancer Early Detection Program on Cervical Cancer Mortality Among Uninsured Low-Income Womenin the U.S., 1991?2007;Ekwueme DU1, Uzunangelov VJ2, Hoerger TJ3, Miller JW4, Saraiya M4, Benard VB4, Hall IJ4, Royalty J4, Li C4, Myers ER5.;2014
Noneg;hassan2009.pdf;impact of whole-body ct screening on the cost-effectiveness of ct colonography;Hassan C1, Pickhardt PJ, Laghi A, Zullo A, Kim DH, Iafrate F, Di Giulio L, Morini S.;2009
Noneg;blanks2006.pdf;improving the nhs cervical screening laboratory performance indicators by making allowance for population age risk and screening interval;Blanks RG1, Moss SM, Denton K.;2006
Anton;westra2013.pdf;Inclusion of the benefits of enhanced cross protection against cervical cancer and prevention of genital warts in the cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands;Westra TA1, Stirbu-Wagner I, Dorsman S, Tutuhatunewa ED, de Vrij EL, Nijman HW, Daemen T, Wilschut JC, Postma MJ.;2013
Noneg;chauvin2011.pdf;incremental net benefit and acceptability of alternative health policies a case study of mass screening for colorectal cancer;Chauvin P1, Josselin JM, Heresbach D.;2012
Anton;gulati2014.pdf;individualized estimates of overdiagnosis in screen-detected prostate cancer;Gulati, Roman  Inoue, Lurdes Y. T.  Gore, John L.  Katcher, Jeffrey  Etzioni, Ruth;2014
Anton;castle2018.pdf;inefficiencies of over-screening and under-screening for cervical cancer prevention in the us;Castle, Philip E.  Wheeler, Cosette M.  Campos, Nicole G.  Sy, Stephen  Burger, Emily A.  Kim, Jane J.;2018
Noneg;berhane2003.pdf;Inference in Spline-Based Models for Multiple Time-to-Event Data, with Applications to a Breast Cancer Prevention Trial ;Berhane, K, Weissfeld, LA;2003
Noneg;jiang2015.pdf;inference on cancer screening exam accuracy using population-level administrative data;Jiang H1, Brown PE1,2,3, Walter SD2.;2016
Anton;10.1093@epirev@mxr009.pdf;interpreting overdiagnosis estimates in population-based mammography screening;de Gelder R1, Heijnsdijk EA, van Ravesteyn NT, Fracheboud J, Draisma G, de Koning HJ.;2011
Noneg;lane2010.pdf;Interval Fecal Immunochemical Testing in a Colonoscopic Surveillance Program Speeds Detection of Colorectal Neoplasia;Lane JM1, Chow E, Young GP, Good N, Smith A, Bull J, Sandford J, Morcom J, Bampton PA, Cole SR.;2010
q12;yamamoto2011.pdf;introducing hpv vaccine and scaling up screening procedures to prevent deaths from cervical cancer in japan a cost-effectiveness analysis;Yamamoto N1, Mori R, Jacklin P, Osuga Y, Kawana K, Shibuya K, Taketani Y.;2012
Noneg;alagoz2018.pdf;introduction to the cancer intervention and surveillance modeling network cisnet breast cancer models;Alagoz, Oguzhan, Berry, Donald A., de Koning, Harry J., Feuer, Eric J., Lee, Sandra J., Plevritis, Sylvia K., Schechter, Clyde B., Stout, Natasha K., Trentham-Dietz, Amy, Mandelblatt, Jeanne S.;2018
Noneg;hosking2013.pdf;investigating interventions for increasing colorectal cancer screening insights from a simulation model;Hosking, Michael, Roberts, Stephen, Uzsoy, Reha, Joseph, Talisa M.;2013
Noneg;connor2000.pdf;investigation of design and bias issues in case-control studies of cancer screening using microsimulation;;2000
q12;accetta2010.pdf;is human papillomavirus screening preferable to current policies in vaccinated and unvaccinated women a cost-effectiveness analysis;Accetta G1, Biggeri A, Carreras G, Lippi G, Carozzi FM, Confortini M, Zappa M, Paci E.;2010
Anton;pataky2014.pdf;is prostate cancer screening cost-effective a microsimulation model of prostate-specific antigen-based screening for british columbia canada;Pataky, Reka  Gulati, Roman  Etzioni, Ruth  Black, Peter  Chi, Kim N.  Coldman, Andrew J.  Pickles, Tom  Tyldesley, Scott  Peacock, Stuart;2014
Anton;pickhardt2008.pdf;is there sufficient mdct capacity to provide colorectal cancer screening with ct colonography for the us population;Pickhardt P.J., Hassan C., Laghi A., Kim D.H., Zullo A., Iafrate F., Morini S.;2008
Noneg;park2013.pdf;korean risk assessment model for breast cancer risk prediction;Park B., Ma S.H., Shin A., Chang M.-C., Choi J.-Y., Kim S., Han W., Noh D.-Y., Ahn S.-H., Kang D., Yoo K.-Y., Park S.K.;2013
Anton;djp001.pdf;lead time and overdiagnosis in prostate-specific antigen screening importance of methods and context;Draisma, Gerrit  Etzioni, Ruth  Tsodikov, Alex  Mariotto, Angela  Wever, Elisabeth  Gulati, Roman  Feuer, Eric  de Koning, Harry;2009
Anton;draisma2003.pdf;lead times and overdetection due to prostate-specific antigen screening estimates from the european randomized study of screening for prostate cancer;Draisma, G  Boer, R  Otto, SJ  van der Cruijsen, IW  Damhuis, RAM  Schroder, FH  de Koning, HJ;2003
q12;lefevere2011.pdf;like mother like daughter mothers history of cervical cancer screening and daughters human papillomavirus vaccine uptake in flanders belgium;Lefevere E1, Hens N, Theeten H, Van den Bosch K, Beutels P, De Smet F, Van Damme P.;2011
Anton;geurts2015.pdf;likely effect of adding flexible sigmoidoscopy to the english nhs bowel cancer screening programme impact on colorectal cancer cases and deaths;Geurts, S. M. E.  Massat, N. J.  Duffy, S. W.;2015
Anton;etzioni2013.pdf;limitations of basing screening policies on screening trials the us preventive services task force and prostate cancer screening;Etzioni, Ruth  Gulati, Roman  Cooperberg, Matt R.  Penson, David M.  Weiss, Noel S.  Thompson, Ian M.;2013
Anton;lew2017.pdf;Long-term evaluation of benefits, harms, and cost-effectiveness of the National Bowel Cancer Screening Program in Australia: a modelling study;Lew, Jie-Bin  St John, D. James B.  Xu, Xiang-Ming  Greuter, Marjolein J. E.  Caruana, Michael  Cenin, Dayna R.  He, Emily  Saville, Marion  Grogan, Paul  Coupe, Veerle M. H.  Canfell, Karen;2017
Anton;hassan2012.pdf;loss of efficacy and cost-effectiveness when screening colonoscopy is performed by nongastroenterologists;Hassan, Cesare  Rex, Douglas K.  Zullo, Angelo  Cooper, Gregory S.;2012
;ajph.2018.304659.pdf;lung cancer screening a cost-effective public health imperative; Pyenson B.S., Tomicki S.M. ;2018
FromReview;rijnsburger2004.pdf;MAMMOGRAPHY BENEFIT IN THE CANADIAN NATIONAL BREASTSCREENING STUDY-2: A MODEL EVALUATION;;
FromReview;chien2008.pdf;mean sojourn time and effectiveness of mortality reduction for lung cancer screening with computed tomography;Chien, Chun-Ru  Chen, Tony Hsiu-Hsi;2008
Anton;gogov2016.pdf;Methodological features of prostate cancer screening models ? A review of simulation models;Gogov, D.  Muehlberger, N.  Iskandar, R.  Alimohammadi, Y.  Siebert, U.;2016
Noneg;wilson2001.pdf;model of estimated rates of colorectal cancer from polyp growth by year of surveillance;Wilson, LS, Lightwood, J;2001
Noneg;monsonego2004.pdf;Screening 3 years after negative test, rather than annually, would result in three additional cases of cervical cancer per 100,000 women screened; Monsonego J. ;2004
Anton;barratt2005.pdf;model of outcomes of screening mammography information to support informed choices;Barratt A., Howard K., Irwig L., Salkeld G., Houssami N.;2005
Anton;goldie2011.pdf;model-based analyses to compare health and economic outcomes of cancer control inclusion of disparities;Goldie S.J., Daniels N.;2011
Noneg;parmigiani2002.pdf;modeling and optimization in early detection programs with a single exam;Parmigiani, G, Skates, S, Zelen, M;2002
Anton;goldwasser2009.pdf;modeling excess lung cancer risk among screened arm participants in the mayo lung project;Goldwasser, Deborah L.  Kimmel, Marek;2010
q12;taksler2016.pdf;modeling individual patient preferences for colorectal cancer screening based on their tolerance for complications risk;Taksler, Glen B., Perzynski, Adam T., Kattan, Michael W.;2017
Noneg;rafia2015.pdf;Modeling the cost-effectiveness of Alternative Upper Age Limits for Breast Cancer Screening in England and Wales;Rafia R1, Brennan A2, Madan J3, Collins K4, Reed MW5, Lawrence G6, Robinson T7, Greenberg D8, Wyld L9.;2016
Noneg;subramanian2009.pdf;modeling the cost-effectiveness of colorectal cancer screening policy guidance based on patient preferences and compliance;Cancer Epidemiol Biomarkers Prev. 2009 Jul.18(7):1971-8. doi: 10.1158/1055-9965.EPI-09-0083. Epub 2009 Jun 30.;2003
Anton;feuer2002.pdf;modeling the impact of the decline in distant stage disease on prostate carcinoma mortality rates;Feuer EJ1, Mariotto A, Merrill R.;2002
FromReview;berry2006.pdf;Modeling the Impact of Treatment and Screening on U.S. Breast Cancer Mortality: A Bayesian Approach;Berry DA1, Inoue L, Shen Y, Venier J, Cohen D, Bondy M, Theriault R, Munsell MF.;2006
Anton;schlecht2003.pdf;modeling the time dependence of the association between human papillomavirus infection and cervical cancer precursor lesions;Schlecht N.F., Platt R.W., Negassa A., Duarte-Franco E., Rohan T.E., Ferenczy A., Villa L.L., Franco E.L.;2003
Noneg;nnoaham2008.pdf;modelling future capacity needs and spending on colonoscopy in the english bowel cancer screening programme;Nnoaham KE1, Lines C.;2008
FromReview;nihms783893.pdf;modelling mammography screening for breast cancer in the canadian context modification and testing of a microsimulation model;Yaffe, Martin J.  Mittmann, Nicole  Lee, Pablo  Tosteson, Anna N. A.  Trentham-Dietz, Amy  Alagoz, Oguzhan  Stout, Natasha K.;2015
FromReview;lee2003.pdf;Modelling the early detection of breast cancer;;
Anton;demarteau2010.pdf;modelling the economic value of cross- and sustained-protection in vaccines against cervical cancer;Demarteau N1, Standaert B.;2010
Noneg;uhry2011.pdf;modelling the effect of breast cancer screening on related mortality using french data;Uhry Z1, H??delin G, Colonna M, Asselain B, Arveux P, Exbrayat C, Guldenfelds C, Soler-Michel P, Molini?? F, Tr??tarre B, Rogel A, Courtial I, Danzon A, Guizard AV, Ancelle-Park R, Eilstein D, Duffy S.;2011
Noneg;etzioni2004.pdf;modelling the effect of screening for cervical cancer on the population;Comment,Female,Humans,Models, Statistical,Population Surveillance*,United Kingdom/epidemiology,Uterine Cervical Neoplasms/diagnosis*,Uterine Cervical Neoplasms/epidemiology,Uterine Cervical Neoplasms/mortality;1526
Noneg;johnston2001.pdf;modelling the future costs of breast screening;Johnston K1.;2001
Noneg;taylor2010.pdf;modelling the impact of changes in sensitivity on the outcomes of the uk breast screening programme;Taylor P1.;2010
q12;mccann2004.pdf;Modelling the impact of detecting and treating carcinoma in situ in a breast screening programme;McCann J1, Treasure P, Duffy S.;2004
Noneg;woo2005.pdf;modelling the impact of population-based cytologic screening on cervical cancer incidence and mortality in hong kong an age-period-cohort approach;Woo P.P.S., Thach T.Q., Choy S.T.B., McGhee S.M., Leung G.M.;2005
Anton;gunsoy2012.pdf;Modelling the overdiagnosis of breast cancer due to mammography screening in women aged 40to 49 in the United Kingdom;Gunsoy, Necdet B.  Garcia-Closas, Montserrat  Moss, Sue M.;2012
q12;canfell2010.pdf;models of cervical screening in the era of human papillomavirus vaccination;Canfell K1.;2010
Noneg;blanks2004.pdf;monitoring and evaluating the performance of the uk nhs cervical screening programme monitoring performance by using cytology outcomes adjusted for population characteristics;Cytopathology. 2004 Feb.15(1):5-11.;2000
Noneg;berkowitz2018.pdf;multilevel small-area estimation of colorectal cancer screening in the united states;Berkowitz Z., Zhang X., Richards T.B., Nadel M., Peipins L.A., Holt J.;2018
Anton;uhry2010.pdf;multi-state markov models in cancer screening evaluation a brief review and case study;Uhry, Z.  Hedelin, G.  Colonna, M.  Asselain, B.  Arveux, P.  Rogel, A.  Exbrayat, C.  Guldenfels, C.  Courtial, I.  Soler-Michel, P.  Molinie, F.  Eilstein, D.  Duffy, S. W.;2010
Noneg;sutradhar2016.pdf;multistate transitional models for measuring adherence to breast cancer screening a population-based longitudinal cohort study with over two million women;Sutradhar R1,2,3, Gu S1, Paszat LF1,2,4.;2017
Noneg;berkhof2005.pdf;natural history and screening model for high-risk human papillomavirus infection neoplasia and cervical cancer in the netherlands;Berkhof J1, de Bruijne MC, Zielinski GD, Meijer CJ.;2005
Anton;10.1002@cncr.29952.pdf;nonbleeding adenomas evidence of systematic false-negative fecal immunochemical test results and their implications for screening effectiveness-a modeling study;van der Meulen, Miriam P.  Lansdorp-Vogelaar, Iris  van Heijningen, Else-Mariette B.  Kuipers, Ernst J.  van Ballegooijen, Marjolein;2016
Anton;price2016.pdf;Operations research models and methods in the screening, detection, and treatment of prostate cancer: A categorized, annotated review;Price, Stuart  Golden, Bruce  Wasil, Edward  Denton, Brian T.;2016
Anton;10.1111@1475-6773.12246.pdf;Optimal Colorectal Cancer Screening in States? Low-Income, Uninsured Populations The Case of South Carolina;van der Steen, Alex  Knudsen, Amy B.  van Hees, Frank  Walter, Gailya P.  Berger, Franklin G.  Daguise, Virginie G.  Kuntz, Karen M.  Zauber, Ann G.  van Ballegooijen, Marjolein  Lansdorp-Vogelaar, Iris;2015
Anton;bertsimas2016.pdf;optimal healthcare decision making under multiple mathematical models application in prostate cancer screening;Bertsimas, Dimitris  Silberholz, John  Trikalinos, Thomas;2018
Noneg;sekiguchi2015.pdf;optimal use of colonoscopy and fecal immunochemical test for population-based colorectal cancer screening a cost-effectiveness analysis using japanese data;Jpn J Clin Oncol. 2016 Feb.46(2):116-25. doi: 10.1093/jjco/hyv186. Epub 2015 Dec 18.;2015
q12;rogoza2008.pdf;optimization of primary and secondary cervical cancer prevention strategies in an era of cervical cancer vaccination a multi-regional health economic analysis;Rogoza RM1, Ferko N, Bentley J, Meijer CJ, Berkhof J, Wang KL, Downs L, Smith JS, Franco EL.;2008
FromReview;zhang2012.pdf;Optimization of Prostate Biopsy Referral Decisions;;
FromReview;zhang2011.pdf;Optimization of PSA Screening Policies: A Comparison of the Patient and Societal Perspectives;;
Noneg;meester2018.pdf;optimizing colorectal cancer screening by race and sex microsimulation analysis ii to inform the american cancer society colorectal cancer screening guideline;Meester, Reinier G. S., Peterse, Elisabeth F. P., Knudsen, Amy B., de Weerdt, Anne C., Chen, Jennifer C., Lietz, Anna P., Dwyer, Andrea, Ahnen, Dennis J., Siegel, Rebecca L., Smith, Robert A., Zauber, Ann G., Lansdorp-Vogelaar, Iris;2018
Noneg;wong2012.pdf;optimizing resource allocation for breast cancer prevention and care among hong kong chinese women;Cancer. 2012 Sep 15.118(18):4394-403. doi: 10.1002/cncr.27448. Epub 2012 Feb 22.;2012
FromReview;tappenden2007.pdf;option appraisal of population-based colorectal cancer screening programmes in england;Tappenden P1, Chilcott J, Eggington S, Patnick J, Sakai H, Karnon J.;2007
Anton;navernik2014.pdf;output correlations in probabilistic models with multiple alternatives;Naversnik K.;2015
Anton;seigneurin2016.pdf;overdiagnosis and overtreatment associated with breast cancer mammography screening a simulation study with calibration to population-based data;Seigneurin, Arnaud  Labarere, Joee  Francois, Olivier  Exbrayat, Catherine  Dupouy, Maylis  Filippi, Marc  Colonna, Marc;2016
Anton;duffy2005.pdf;overdiagnosis and overtreatment of breast cancer - estimates of overdiagnosis from two trials of mammographic screening for breast cancer;Duffy, SW  Agbaje, O  Tabar, L  Vitak, B  Bjurstam, N  Bjorneld, L  Myles, JP  Warwick, J;2005
Anton;10.1186@bcr1369.pdf;overdiagnosis and overtreatment of breast cancer microsimulation modelling estimates based on observed screen and clinical data;de Koning HJ1, Draisma G, Fracheboud J, de Bruijn A.;2006
Anton;seigneurin2015.pdf;overdiagnosis associated with breast cancer screening a simulation study to compare lead-time adjustment methods;Seigneurin A., Labarere J., Duffy S.W., Colonna M.;2015
Anton;etzioni2002.pdf;overdiagnosis due to prostate-specific antigen screening lessons from us prostate cancer incidence trends;Etzioni, R  Penson, DF  Legler, JM  di Tommaso, D  Boer, R  Gann, PH  Feuer, EJ;2002
Anton;olsen2006.pdf;overdiagnosis sojourn time and sensitivity in the copenhagen mammography screening program;Olsen A.H., Agbaje O.F., Myles J.P., Lynge E., Duffy S.W.;2006
Noneg;nghiem2016.pdf;overtreatment and cost-effectiveness of the see-and-treat strategy for managing cervical precancer;Cancer Epidemiol Biomarkers Prev. 2016 May.25(5):807-14. doi: 10.1158/1055-9965.EPI-15-1044. Epub 2016 Feb 29.;2012
Anton;10.1016@s0959-80490000330-0.pdf;Overview of important cervical cancer screening process values inEuropean Union (EU) countries, and tentative predictions of the corresponding effectiveness and cost-effectiveness;Van Ballegooijen M., Van den Akker-van Marle E., Patnick J., Lynge E., Arbyn M., Anttila A., Ronco G., Dik J., Habbema F.;2000
Noneg;10.1371@journal.pmed.1002225.pdf;performance and cost-effectiveness of computed tomography lung cancer screening scenarios in a population-based setting a microsimulation modeling analysis in ontario canada;Ten Haaf K1, Tammem?gi MC2, Bondy SJ3,4, van der Aalst CM1, Gu S5, McGregor SE6, Nicholas G7, de Koning HJ1, Paszat LF3,5.;2017
Anton;arnold2018.pdf;personalized mammography screening and screening adherence-a simulation and economic evaluation;Arnold, Matthias  Quante, Anne S.;2018
Noneg;subramanian2017.pdf;Personalized medicine for prevention: can risk stratified screening decrease colorectal cancer mortality at an acceptable cost?;Subramanian, Sujha, Bobashev, Georgiy, Morris, Robert J., Hoover, Sonja;2017
FromReview;macafee2008.pdf;population screening for colorectal cancer the implications of an ageing population;Macafee, D. A. L.  Waller, M.  Whynes, D. K.  Moss, S.  Scholefield, J. H.;2008
Noneg;marshall2001.pdf;Potential cost-effectiveness of one-time screening for lung cancer (LC) in a high risk cohort;Marshall D1, Simpson KN, Earle CC, Chu C.;2001
q12;kulasingam2003.pdf;Potential Health and Economic Impact of Adding a Human Papillomavirus Vaccine to Screening Programs;Kulasingam SL1, Myers ER.;2003
Noneg;seppnen2008.pdf;predicting impacts of mass-screening policy changes on breast cancer mortality;Sepp?nen J1, Hein?vaara S, Hakulinen T.;2008
Anton;chiu2017.pdf;predicting the effectiveness of the finnish population-based colorectal cancer screening programme;Chiu, Sherry Yueh-Hsia  Malila, Nea  Yen, Amy Ming-Fang  Chen, Sam Li-Sheng  Fann, Jean Ching-Yuan  Hakama, Matti;2017
Noneg;parkin2008.pdf;predicting the impact of the screening programme for colorectal cancer in the uk;Parkin, D. M., Tappenden, P., Olsen, A. H., Patnick, J., Sasieni, P.;2008
Anton;zelle2014.pdf;predicting the stage shift as a result of breast cancer screening in low- and middle-income countries a proof of concept;Zelle SG1, Baltussen R2, Otten JD3, Heijnsdijk EA4, van Schoor G2, Broeders MJ5.;2015
Noneg;castanon2018.pdf;prediction of cervical cancer incidence in england uk up to 2040 under four scenarios a modelling study;Castanon, Alejandra, Landy, Rebecca, Pesola, Francesca, Windridge, Peter, Sasieni, Peter;2018
Anton;10.1038@bjc.2011.300.pdf;prediction of higher mortality reduction for the uk breast screening frequency trial a model-based approach on screening intervals;van Ravesteyn, N. T.  Heijnsdijk, E. A. M.  Draisma, G.  de Koning, H. J.;2011
q12;canfell2011.pdf;prevention of cervical cancer in rural china evaluation of hpv vaccination and primary hpv screening strategies;Canfell K1, Shi JF, Lew JB, Walker R, Zhao FH, Simonella L, Chen JF, Legood R, Smith MA, Nickson C, Qiao YL.;2011
Noneg;10.1136@bmj.e670.pdf;Primary screening for human papillomavirus compared with cytology screening for cervical cancer in European settings: costeffectiveness analysis based on a Dutch microsimulation model;de Kok IM1, van Rosmalen J, Dillner J, Arbyn M, Sasieni P, Iftner T, van Ballegooijen M.;2012
Noneg;tafazzoli2009.pdf;probabilistic cost-effectiveness comparison of screening strategies for colorectal cancer;Tafazzoli, Ali, Roberts, Stephen, Klein, Robert, Ness, Reid, Dittus, Robert;2009
Noneg;rojnik2008.pdf;probabilistic cost-effectiveness modeling of different breast cancer screening policies in slovenia;Rojnik K1, Naversnik K, Mateovi??-Rojnik T, Primiczakelj M.;2008
q12;bradley2011.pdf;Productivity Savings from Colorectal Cancer Prevention and Control Strategies;Bradley, Cathy J., Lansdorp-Vogelaar, Iris, Yabroff, Robin, Dahman, Bassam, Mariotto, Angela, Feuer, Eric J., Brown, Martin L.;2011
Noneg;melnikow2013.pdf;program-specific cost-effectiveness analysis breast cancer screening policies for a safety-net program;Melnikow J1, Tancredi DJ, Yang Z, Ritley D, Jiang Y, Slee C, Popova S, Rylett P, Knutson K, Smalley S.;2013
Anton;goldie2004.pdf;projected clinical benefits and cost-effectiveness of a human papillomavirus 1618 vaccine;Goldie SJ1, Kohli M, Grima D, Weinstein MC, Wright TC, Bosch FX, Franco E.;2004
Anton;roth2015.pdf;projected clinical resource use and fiscal impacts of implementing low-dose computed tomography lung cancer screening in medicare;Roth, Joshua A.  Sullivan, Sean D.  Goulart, Bernardo H. L.  Ravelo, Arliene  Sanderson, Joanna C.  Ramsey, Scott D.;2015
FromReview;stensson2013.pdf;Projected cost-effectiveness of repeat high-risk human papillomavirus testing using self-collected vaginal samples in the Swedish cervical cancer screening program;;
Noneg;coldman2017.pdf;projected effect of fecal immunochemical test threshold for colorectal cancer screening on outcomes and costs for canada using the oncosim microsimulation model;Coldman, Andrew, Flanagan, William, Nadeau, Claude, Wolfson, Michael, Fitzgerald, Natalie, Memon, Saima, Gauvreau, Cindy, Miller, Anthony, Earle, Craig;2017
Anton;10.1080@21645515.2015.1054584.pdf;Projected impact of Cervarix vaccination on oncogenic human papillomavirus infection and cervical cancer in the United Kingdom;Van Effelterre TP1, Hogea C2, Taylor SM1.;2016
Anton;birnbaum2015.pdf;Projecting Benefits and Harms of Novel Cancer Screening Biomarkers: A Study of PCA3 and Prostate Cancer;Birnbaum, Jeanette K.  Feng, Ziding  Gulati, Roman  Fan, Jing  Lotan, Yair  Wei, John T.  Etzioni, Ruth;2015
Anton;armstrong2010.pdf;prophylaxis of cervical cancer and related cervical disease a review of the cost-effectiveness of vaccination against oncogenic hpv types;Armstrong EP1.;2010
Anton;kobayashi2007.pdf;prostate cancer screening strategies with re-screening interval determined by individual baseline prostate-specific antigen values are cost-effective;Kobayashi, T.  Goto, R.  Ito, K.  Mitsumori, K.;2007
Noneg;stone2005.pdf;prostate cancer the psa test and academic detailing in australian general practice an economic evaluation;Stone CA1, May FW, Pinnock CB, Elwood M, Rowett DS.;2005
Anton;wever2010.pdf;prostate-specific antigen screening in the united states vs in the european randomized study of screening for prostate cancer-rotterdam;Wever, Elisabeth M.  Draisma, Gerrit  Heijnsdijk, Eveline A. M.  Roobol, Monique J.  Boer, Rob  Otto, Suzie J.  de Koning, Harry J.;2010
Anton;matthijsse2016.pdf;public health benefits of routine human papillomavirus vaccination for adults in the netherlands a mathematical modeling study;Matthijsse SM1, Hontelez JA2, Naber SK1, Rozemeijer K1, de Kok IM1, Bakker R1, van Ballegooijen M1, van Rosmalen J3, de Vlas SJ1.;2016
Anton;meester2015.pdf;public health impact of achieving 80 colorectal cancer screening rates in the united states by 2018;Meester, Reinier G. S.  Doubeni, Chyke A.  Zauber, Ann G.  Goede, S. Luuk  Levin, Theodore R.  Corley, Douglas A.  Jemal, Ahmedin  Lansdorp-Vogelaar, Iris;2015
Anton;10.1007@s00038-011-0273-5.pdf;public health impact of human papillomavirus vaccination on prevention of cervical cancer in france;El Hasnaoui A1, Demarteau N, Granados D, Standaert B, Detournay B.;2012
Anton;stoykova2008.pdf;putting national institute for health and clinical excellence guidance into practice a cost minimization model of a national roll-out of liquid based cytology in england;Stoykova B1, Kuzmanov G, Dowie R.;2008
Anton;yang2018.pdf;quality assurance target for community-based breast cancer screening in china a model simulation;Yang, Lan  Wang, Jing  Cheng, Juan  Wang, Yuan  Lu, Wenli;2018
Anton;10.1002@ijc.31265.pdf;Quality of life assumptions determine which cervical cancer screening strategies are cost-effective;de Kok, Inge M. C. M.  Korfage, Ida J.  van den Hout, Wilbert B.  Helmerhorst, Theo J. M.  Habbema, J. Dik F.  Essink-Bot, Marie-Louise  van Ballegooijen, Marjolein;2018
Anton;lang2011.pdf;quality of life treatments and patients willingness to pay for a complete remission of cervical cancer in taiwan;Lang HC1, Chang K, Ying YH.;2012
Anton;jansen2013.pdf;quantifying lead-time bias in risk factor studies of cancer through simulation;Jansen RJ1, Alexander BH, Anderson KE, Church TR.;2013
Anton;yen2003.pdf;quantifying the potential problem of overdiagnosis of ductal carcinoma in situ in breast cancer screening;Yen, MF  Tabar, L  Vitak, B  Smith, RA  Chen, HH  Duffy, SW;2003
Anton;10.2307@40271855.pdf;quantifying the role of psa screening in the us prostate cancer mortality decline;Etzioni, Ruth  Tsodikov, Alex  Mariotto, Angela  Szabo, Aniko  Falcon, Seth  Wegelin, Jake  ditommaso, Dante  Karnofski, Kent  Gulati, Roman  Penson, David F.  Feuer, Eric;2008
Noneg;heijnsdijk2014.pdf;re cost-effectiveness of prostate cancer screening a simulation study based on erspc data;Noordzij, M. Arjen, Blanker, Marco H.;2015
Noneg;whyte2012.pdf;reappraisal of the options for colorectal cancer screening in england;Whyte S1, Chilcott J, Halloran S.;2012
Noneg;eaker2001.pdf;reasons women do not attend screening for cervical cancer a population-based study in sweden;Eaker S., Adami H.-O., Sparen P.;2001
Noneg;bouee2009.pdf;relative impact of screening and therapeutic progress on the reduction of breast cancer specific mortality in france a simulation model over the period 1994-2005;Bouee, S., Fagnani, F., Alfonsi, A., Florentin, V;2009
Noneg;knudsen2012.pdf;rescreening of persons with a negative colonoscopy result results from a microsimulation model;Ann Intern Med. 2012 Nov 6.157(9):611-20. doi: 10.7326/0003-4819-157-9-201211060-00005.;1000
Anton;nihms451467.pdf;response reading between the lines of cancer screening trials using modeling to understand the evidence;Etzioni, Ruth  Gulati, Roman;2013
Anton;stout2006.pdf;retrospective cost-effectiveness analysis of screening mammography;Stout, NK  Rosenberg, MA  Trentham-Dietz, A  Smith, MA  Robinson, SM  Fryback, DG;2006
FromReview;jeong2013.pdf;Review of economic evidence in the prevention and early detection of colorectal cancer;;
Noneg;morrell2012.pdf;risk of cervical cancer associated with extending the interval between cervical-cancer screenings;Sawaya GF1, McConnell KJ, Kulasingam SL, Lawson HW, Kerlikowske K, Melnikow J, Lee NC, Gildengorin G, Myers ER, Washington AE.;2003
FromReview;lee1998.pdf;Scheduling Periodic Examinations for the Early Detection of Disease: Applications to Breast Cancer;;
Noneg;beemsterboer1998.pdf;screening for breast cancer in catalonia - which policy is to be preferred;Beemsterboer, PMM, Warmerdam, PG, Boer, R, Borras, JM, Moreno, V, Viladiu, P, De Koning, HJ;1998
Anton;ruile2015.pdf;screening for breast cancer with breast-ct in a prohta simulation;Ruile, Georg  Djanatliev, Anatoli  Kriza, Christine  Meier, Florian  Leb, Ines  Kalender, Willi A.  Kolominsky-Rabas, Peter L.;2015
Anton;10.1002@ijc.29136.pdf;Screening for prostate cancer in the US? Reduce the harms and keep the benefit;de Carvalho, Tiago M.  Heijnsdijk, Eveline A. M.  de Koning, Harry J.;2015
Anton;myers2000.pdf;setting the target for a better cervical screening test characteristics of a cost-effective test for cervical neoplasia screening;Myers ER1, McCrory DC, Subramanian S, McCall N, Nanda K, Datta S, Matchar DB.;2000
FromReview;10.7326@m13-2263.pdf;Should Colorectal Cancer Screening Be Considered in Elderly Persons Without Previous Screening? A cost-effectiveness Analysis;;
Noneg;klemi2003.pdf;significant improvement in breast cancer survival through population-based mammography screening;Klemi PJ1, Parvinen I, Pylkk?nen L, Kauhava L, Immonen-R?ih? P, R?s?nen O, Helenius H.;2003
q12;10.1177@0272989x17711928.pdf;simulating the impact of risk-based screening and treatment on breast cancer outcomes with miscan-fadia;van den Broek, Jeroen J., van Ravesteyn, Nicolien T., Heijnsdijk, Eveline A., de Koning, Harry J.;2018
Noneg;dreyfuss2009.pdf;Simulation Model Predicts Cost Savings from Colorectal Cancer Screening;Dreyfuss, John Henry;2010
Noneg;hunter2004.pdf;simulation modeling of change to breast cancer detection age eligibility recommendations in ontario 2002-2021;Hunter DJ1, Drake SM, Shortt SE, Dorland JL, Tran N.;2004
FromReview;10.1016@j.bpg.2010.07.001.pdf;Simulation of colorectal cancer screening: What we do and do not know and does it matter;;
FromReview;underwood2012.pdf;simulation optimization of psa-threshold based prostate cancer screening policies;Underwood, Daniel J.  Zhang, Jingyu  Denton, Brian T.  Shah, Nilay D.  Inman, Brant A.;2012
Anton;goldwasser2012.pdf;small median tumor diameter at cure threshold20 mm among aggressive non-small cell lung cancers in male smokers predicts both chest x-ray and ct screening outcomes in a novel simulation framework;Goldwasser, Deborah L.  Kimmel, Marek;2013
Anton;yeh2013.pdf;sorting it out pile sorting as a mixed methodology for exploring barriers to cancer screening;Yeh, Hung-Wen  Gajewski, Byron J.  Perdue, David G.  Cully, Angel  Cully, Lance  Greiner, K. Allen  Choi, Won S.  Daley, Christine Makosy;2014
Noneg;boer1999.pdf;stage distribution at first and repeat examinations in breast cancer screening;Boer R1, de Koning H, van Oortmarssen G, Warmerdam P, van der Maas P.;1999
Anton;lansdorpvogelaar2015.pdf;state disparities in colorectal cancer rates contributions of risk factors screening and survival differences;Lansdorp-Vogelaar, Iris  Goede, S. Lucas  Ma, Jiemin  Wu Xiau-Cheng  Pawlish, Karen  van Ballegooijen, Marjolein  Jemal, Ahmedin;2015
Noneg;crt-2016-525.pdf;strategic distributional cost-effectiveness analysis for improving national cancer screening uptake in cervical cancer a focus on regional inequality in south korea;Lee TH1,2, Kim W1,2, Shin J2,3, Park EC2,3, Park S2,4, Kim TH2,4.;2018
q12;kivutibitok2014.pdf;system dynamics model of cervical cancer vaccination and screening interventions in kenya;Kivuti-Bitok, Lucy W., McDonnell, Geoff, Abdul, Roudsari, Pokhariyal, Ganesh P.;2014
FromReview;mendes2015.pdf;Systematic review of model-based cervical screening evaluations;;
Anton;felix2016.pdf;the clinical and economic benefits of co-testing versus primary hpv testing for cervical cancer screening a modeling analysis;Felix, Juan C.  Lacey, Michael J.  Miller, Jeffrey D.  Lenhart, Gregory M.  Spitzer, Mark  Kulkarni, Rucha;2016
FromReview;gangnon2015.pdf;The Contribution of Mammography Screening to Breast Cancer Incidence Trends in the United States: An Updated Age-period-cohort Model;;
Noneg;field2013.pdf;the contribution of risk prediction models to early detection of lung cancer;Field JK1, Chen Y, Marcus MW, Mcronald FE, Raji OY, Duffy SW.;2013
Noneg;anderson2008.pdf;the cost-effectiveness of cervical screening in australia what is the impact of screening at different intervals or over a different age range;Anderson R1, Haas M, Shanahan M.;2008
Noneg;lejeune2014.pdf;the cost-effectiveness of immunochemical tests for colorectal cancer screening;Lejeune C1, Le Gleut K2, Cottet V3, Galimard C4, Durand G2, Dancourt V3, Faivre J3.;2014
FromReview;wisnivesky2003.pdf;The cost-effectiveness of Low-Dose CT Screening for Lung Cancer*Preliminary Results of Baseline Screening;;
FromReview;dewilde2004.pdf;the cost-effectiveness of screening programs using single and multiple birth cohort simulations a comparison using a model of cervical cancer;Dewilde S., Anderson R.;2004
Noneg;sander2016.pdf;the cost-utility of integrated cervical cancer prevention strategies in the ontario setting - can we do better;Vaccine. 2016 Apr 7.34(16):1936-44. doi: 10.1016/j.vaccine.2016.02.016. Epub 2016 Feb 15.;2007
FromReview;lee2018.pdf;The Dana-Farber CISNET Model for BreastCancer Screening Strategies: An Update;;
Anton;blanks2008.pdf;the development of the referral outcome diagram and an analysis of laboratory cancer detection rates in the english nhs cervical screening programme--is there an optimum level of detection of cin 1 and cin 2 lesions;Blanks RG1.;2008
q12;birnbaum2016.pdf;the effect of treatment advances on the mortality results of breast cancer screening trials a microsimulation model;Birnbaum J, Gadi VK, Markowitz E, Etzioni R.;2016
q12;duffy2016.pdf;the effects of population-based mammography screening starting between age 40 and 50 in the presence of adjuvant systemic therapy;de Gelder R1, Heijnsdijk EA, Fracheboud J, Draisma G, de Koning HJ.;2015
Anton;uuskla2013.pdf;The epidemiological and economic impact of aqua-drivalent human papillomavirus (hpv) vaccine in Estonia;Uuskula A., Muursepp A., Kawai K., Raag M., Jurisson M., Pillsbury M.;2013
Anton;siebert2005.pdf;the german cervical cancer screening model development and validation of a decision-analytic model for cervical cancer screening in germany;Siebert, U  Sroczynski, G  Hillemanns, P  Engel, J  Stabenow, R  Stegmaier, C  Voigt, K  Gibis, B  Holzel, D  Goldie, SJ;2006
Anton;berkhof2010.pdf;the health and economic effects of hpv dna screening in the netherlands;Berkhof, Johannes  Coupe, Veerle M.  Bogaards, Johannes A.  van Kemenade, Folkert J.  Helmerhorst, Theo J.  Snijders, Peter J.  Meijer, Chris J.;2010
Noneg;campos2017.pdf;the health and economic impact of scaling cervical cancer prevention in 50 low- and lower-middle-income countries;Int J Gynaecol Obstet. 2017 Jul.138 Suppl 1:47-56. doi: 10.1002/ijgo.12184.;2017
q12;tay2011.pdf;the impact of cytology screening and hpv vaccination on the burden of cervical cancer;Tay K1, Tay SK.;2011
Anton;hestbech2015.pdf;the impact of hpv vaccination on future cervical screening a simulation study of two birth cohorts in denmark;Hestbech, Mie Sara  Lynge, Elsebeth  Kragstrup, Jakob  Siersma, Volkert  Baillet, Miguel Vazquez-Prada  Brodersen, John;2015
Noneg;ventura2014.pdf;the impact of immunochemical faecal occult blood testing on colorectal cancer incidence;Dig Liver Dis. 2014 Jan.46(1):82-6. doi: 10.1016/j.dld.2013.07.017. Epub 2013 Sep 4.;1990
Anton;han2017.pdf;The impact of overdiagnosis on the selection of efficient lung cancer screening strategies;Han, Summer S.  ten Haaf, Kevin  Hazelton, William D.  Munshi, Vidit N.  Jeon, Jihyoun  Erdogan, Saadet A.  Johanson, Colden  McMahon, Pamela M.  Meza, Rafael  Kong, Chung Yin  Feuer, Eric J.  de Koning, Harry J.  Plevritis, Sylvia K.;2017
Anton;gulati2012.pdf;the impact of plco control arm contamination on perceived psa screening efficacy;Gulati, Roman  Tsodikov, Alex  Wever, Elisabeth M.  Mariotto, Angela B.  Heijnsdijk, Eveline A. M.  Katcher, Jeffrey  de Koning, Harry J.  Etzioni, Ruth;2012
Noneg;goede2015.pdf;the impact of stratifying by family history in colorectal cancer screening programs;Int J Cancer. 2015 Sep 1.137(5):1119-27. doi: 10.1002/ijc.29473. Epub 2015 Feb 20.;2008
Noneg;peterse2018.pdf;the impact of the rising colorectal cancer incidence in young adults on the optimal age to start screening microsimulation analysis i to inform the american cancer society colorectal cancer screening guideline;Peterse, Elisabeth F. P., Meester, Reinier G. S., Siegel, Rebecca L., Chen, Jennifer C., Dwyer, Andrea, Ahnen, Dennis J., Smith, Robert A., Zauber, Ann G., Lansdorp-Vogelaar, Iris;2018
Noneg;omahony2014.pdf;the influence of disease risk on the optimal time interval between screens for the early detection of cancer a mathematical approach;O'Mahony JF1,2, van Rosmalen J1,3, Mushkudiani NA4, Goudsmit FW1, Eijkemans MJ5, Heijnsdijk EA1, Steyerberg EW1, Habbema JD1.;2015
Noneg;chauvin2013.pdf;The influence of waiting times on cost-effectiveness: a case study of colorectal cancer mass screening;Chauvin P1, Josselin JM, Heresbach D.;2014
Anton;wu2012.pdf;The Lead Time Distribution When Lifetime is Subject to Competing Risks in Cancer Screening;Wu D1, Kafadar K, Rosner GL, Broemeling LD.;2012
Anton;schillerfruehwirth2017.pdf;the long-term effectiveness and cost-effectiveness of organized versus opportunistic screening for breast cancer in austria;Schiller-Fruehwirth, Irmgard  Jahn, Beate  Einzinger, Patrick  Zauner, Guenther  Urach, Christoph  Siebert, Uwe;2017
Noneg;loeve1999.pdf;the miscan-colon simulation model for the evaluation of colorectal cancer screening;Loeve, F, Boer, R, van Oortmarssen, GJ, van Ballegooijen, M, Habbema, JDF;1999
Noneg;tubiana1990.pdf;the natural history of breast cancer implications for a screening strategy;Int J Radiat Oncol Biol Phys. 1990 Nov.19(5):1117-20.;1951
FromReview;flehinger1987.pdf;The Natural History of Lung Cancer in a Periodically Screened Population;;
Anton;muhlberger2015.pdf;the oncotyrol prostate cancer outcome and policy model effect of prevalence assumptions on the benefit-harm balance of screening;Muehlberger, Nikolai  Kurzthaler, Christina  Iskandar, Rowan  Krahn, Murray D.  Bremner, Karen E.  Oberaigner, Willi  Klocker, Helmut  Horninger, Wolfgang  Conrads-Frank, Annette  Sroczynski, Gaby  Siebert, Uwe;2015
q12;sinanovic2009.pdf;the potential cost-effectiveness of adding a human papillomavirus vaccine to the cervical cancer screening programme in south africa;Sinanovic E1, Moodley J, Barone MA, Mall S, Cleary S, Harries J.;2009
Noneg;naber2016.pdf;the potential harms of primary human papillomavirus screening in over-screened women a microsimulation study;Naber SK1, de Kok IM2, Matthijsse SM2, van Ballegooijen M2.;2016
Anton;korostil2014.pdf;The potential impact of HPV-16 reactivation on prevalence in older Australians;Korostil I.A., Regan D.G.;2014
Noneg;canfell2004.pdf;the predicted effect of changes in cervical screening practice in the uk results from a modelling study;Canfell K1, Barnabas R, Patnick J, Beral V.;2004
Noneg;castro2005.pdf;the relation of breast cancer staging to screening protocol compliance a computer simulation study;Castro F1, Carter KJ, Kessler E, Erickson BA, Kseibi SA.;2005
Anton;matthijsse2015.pdf;the role of acquired immunity in the spread of human papillomavirus hpv explorations with a microsimulation model;Matthijsse SM1, van Rosmalen J2, Hontelez JA1, Bakker R1, de Kok IM1, van Ballegooijen M1, de Vlas SJ1.;2015
Noneg;siddiqui2011.pdf;the role of physician reminders in faecal occult blood testing for colorectal cancer screening;Eur J Gen Pract. 2011 Dec.17(4):221-8. doi: 10.3109/13814788.2011.601412. Epub 2011 Aug 23.;1970
Anton;10.1177@0969141316629505.pdf;The role of pre-invasive disease in overdiagnosis: A microsimulation study comparing mass screening for breast cancer and cervical cancer;van Luijt, Paula A.  Rozemeijer, Kirsten  Naber, Steffie K.  Heijnsdijk, Eveline A. M.  van Rosmalen, Joost  van Ballegooijen, Marjolein  de Koning, Harry J.;2016
q12;lgj008.pdf;the spectrum population model of the impact of screening and treatment on us breast cancer trends from 1975 to 2000 principles and practice of the model methods;Mandelblatt J1, Schechter CB, Lawrence W, Yi B, Cullen J.;2006
Noneg;lgj010.pdf;the university of rochester model of breast cancer detection and survival;Hanin LG1, Miller A, Zorin AV, Yakovlev AY.;2006
q12;feuer2004.pdf;The use of modeling to understand the impact of screening on US mortality: examples from mammography and PSA testing;Feuer EJ1, Etzioni R, Cronin KA, Mariotto A.;2004
Noneg;older.pdf;the value of colonoscopic colorectal cancer screening of adults aged 50 to 64 years;Fitch, Kathryn, Pyenson, Bruce, Blumen, Helen, Weisman, Thomas, Small, Art;2015
Anton;burger2014.pdf;the value of improving failures within a cervical cancer screening program an example from norway;Burger EA1, Kim JJ.;2014
q12;sharma2015.pdf;The value of male human papillomavirus vaccination in preventing cervical cancer and genital warts in a low-resource setting;Sharma M., Sy S., Kim J.J.;2016
Noneg;lgj007.pdf;the wisconsin breast cancer epidemiology simulation model;J Natl Cancer Inst Monogr. 2006.(36):37-47.;1975
Anton;luttjeboer2016.pdf;threshold cost-effectiveness analysis for a therapeutic vaccine against hpv-1618-positive cervical intraepithelial neoplasia in the netherlands;Luttjeboer J1, Setiawan D2, Cao Q2, Cahh Daemen T3, Postma MJ4.;2016
Noneg;10.7326@0003-4819-156-9-201205010-00002.pdf;tipping the balance of benefits and harms to favor screening mammography starting at age 40 years a comparative modeling study of risk;van Ravesteyn NT1, Miglioretti DL, Stout NK, Lee SJ, Schechter CB, Buist DS, Huang H, Heijnsdijk EA, Trentham-Dietz A, Alagoz O, Near AM, Kerlikowske K, Nelson HD, Mandelblatt JS, de Koning HJ.;2012
Anton;wever2012.pdf;to be screened or not to be screened modeling the consequences of psa screening for the individual;Wever, E. M.  Hugosson, J.  Heijnsdijk, E. A. M.  Bangma, C. H.  Draisma, G.  de Koning, H. J.;2012
Noneg;campos2017 (1).pdf;to expand coverage or increase frequency quantifying the tradeoffs between equity and efficiency facing cervical cancer screening programs in low-resource settings;Campos NG1, Tsu V2, Jeronimo J2, Mvundura M3, Lee K1,4, Kim JJ1.;2017
Noneg;jgi_05076.pdf;toward optimal screening strategies for older women costs benefits and harms of breast cancer screening by age biology and health status;;2005
Anton;nihms115777.pdf;trade-offs in cervical cancer prevention balancing benefits and risks;Stout NK1, Goldhaber-Fiebert JD, Ortendahl JD, Goldie SJ.;2008
Anton;smith2016.pdf;transitioning from cytology-based screening to hpv-based screening at longer intervals implications for resource use;Smith, Megan A.  Gertig, Dorota  Hall, Michaela  Simms, Kate  Lew, Jie-Bin  Malloy, Michael  Saville, Marion  Canfell, Karen;2016
Anton;duffy2014.pdf;translation of research results to simple estimates of the likely effect of a lung cancer screening programme in the united kingdom;Duffy SW1, Field JK2, Allgood PC1, Seigneurin A3.;2014
Anton;choi2010.pdf;transmission dynamic modelling of the impact of human papillomavirus vaccination in the united kingdom;Choi YH1, Jit M, Gay N, Cox A, Garnett GP, Edmunds WJ.;2010
Noneg;bergstrm1999.pdf;trends in cancer of the cervix uteri in sweden following cytological screening;Bergstrom R., Sparen P., Adami H.-O.;1999
Anton;barnett2017.pdf;two-stage biomarker protocols for improving the precision of early detection of prostate cancer;Barnett, Christine L.  Tomlins, Scott A.  Underwood, Daniel J.  Wei, John T.  Morgan, Todd M.  Montie, James E.  Denton, Brian T.;2017
Noneg;campbell2016.pdf;understanding the effects of competition for constrained colonoscopy services with the introduction of population-level colorectal cancer screening a discrete event simulation model;Campbell, Leslie Anne, Blake, John T., Kephart, George, Grunfeld, Eva, MacIntosh, Donald;2017
q12;beaber2015.pdf;Unifying Screening Processes Within the PROSPR Consortium: A Conceptual Model for Breast, Cervical,and Colorectal Cancer Screening;Beaber EF1, Kim JJ2, Schapira MM2, Tosteson AN2, Zauber AG2, Geiger AM2, Kamineni A2, Weaver DL2, Tiro JA2. Population-based Research Optimizing Screening through Personalized Regimens Consortium.;2015
Noneg;duffy2009.pdf;Use of lung cancer risk models in planning research and service programs in CT screening for lung cancer;Duffy SW1, Raji OY, Agbaje OF, Allgood PC, Cassidy A, Field JK.;2009
Noneg;ramsey2000.pdf;SIMULATION MODELING  OF OUTCOMES AND COST-EFFECTIVENESS ;Ramsey, SD, McIntosh, M, Etzioni, R, Urban, N;2000
Noneg;ramos2005.pdf;Use of risk projection models to estimate mortality and incidence from radiation-induced breast cancer in screening programs;Ramos M1, Ferrer S, Villaescusa JI, Verd? G, Salas MD, Cuevas MD.;2005
Noneg;carney2014.pdf;using computational modeling to assess the impact of clinical decision support on cancer screening improvement strategies within the community health centers;Carney, Timothy Jay, Morgan, Geoffrey P., Jones, Josette, McDaniel, Anna M., Weaver, Michael, Weiner, Bryan, Haggstrom, David A.;2014
Noneg;sharp2013.pdf;Using resource modelling to inform decision making and service planning: the case of colorectal cancer screening in Ireland;Sharp, Linda, Tilson, Lesley, Whyte, Sophie, Ceilleachair, Alan O., Walsh, Cathal, Usher, Cara, Tappenden, Paul, Chilcott, James, Staines, Anthony, Barry, Michael, Comber, Harry;2013
Noneg;taghipour2016.pdf;using simulation to model and validate invasive breast cancer progression in women in the study and control groups of the canadian national breast screening studies i and ii;Taghipour S1, Caudrelier LN2, Miller AB3, Harvey B3.;2017
Noneg;mclay2010.pdf;using simulation-optimization to construct screening strategies for cervical cancer;;2010
Noneg;coldman2015.pdf;using the cancer risk management model to evaluate colorectal cancer screening options for canada;Coldman, A. J., Phillips, N., Brisson, J., Flanagan, W., Wolfson, M., Nadeau, C., Fitzgerald, N., Miller, A. B.;2015
Anton;rutter2016.pdf;validation of models used to inform colorectal cancer screening guidelines accuracy and implications;Rutter, Carolyn M.  Knudsen, Amy B.  Marsh, Tracey L.  Doria-Rose, V. Paul  Johnson, Eric  Pabiniak, Chester  Kuntz, Karen M.  van Ballegooijen, Marjolein  Zauber, Ann G.  Lansdorp-Vogelaar, Iris;2016
Anton;nevalainen2017.pdf;what explains the differences between centres in the european screening trial a simulation study;Nevalainen, Jaakko  Stenman, Ulf-Hakan  Tammela, Teuvo L.  Roobol, Monique  Carlssone, Sigrid  Talalag, Kirsi  Schroder, Fritz H.  Auvinen, Anssi;2017
Noneg;lynge2006.pdf;What happens when organization of cervical cancer screening is delayed or stopped?;Lynge E1, Clausen LB, Guignard R, Poll P.;2006
Noneg;document(1).pdf;What is the most cost-effective screening regimen for colon cancer?;Colonoscopy/economics,Colorectal Neoplasms/mortality,Colorectal Neoplasms/prevention & control*,Cost-Benefit Analysis,Female,Humans,Male,Markov Chains,Mass Screening/economics*,Middle Aged,Occult Blood,Sigmoidoscopy/economics,Survival Analysis;1119
Noneg;subramanian2010.pdf;when budgets are tight there are better options than colonoscopies for colorectal cancer screening;;2010
q12;mandelblatt2013.pdf;which strategies reduce breast cancer mortality most;Mandelblatt, Jeanne, van Ravesteyn, Nicolien, Schechter, Clyde, Chang, Yaojen, Huang, An-Tsun, Near, Aimee M., de Koning, Harry, Jemal, Ahmedin;2013
Noneg;belkar2005.pdf;why worry about awareness in choice problems econometric analysis of screening for cervical cancer;Belkar R1, Fiebig DG, Haas M, Viney R.;2006
FromReview;shen2005.pdf;A Model-Based Comparison of Breast Cancer Screening Strategies: Mammograms and Clinical Breast Examinations;;
Anton;10.1097@00006250-200312000-00035.pdf;Association of funding and conclusions in randomized drug trials: A reflection of treatment effect or adverse events?;;
FromReview;mandelblatt2016.pdf;Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies;;
Anton;ladabaum2016.pdf;Comparative Effectiveness and cost-effectiveness of a Multi-target Stool DNA Test to Screen for Colorectal Neoplasia;;
Anton;posso2016.pdf;cost-effectiveness of Double Reading versus Single Reading of Mammograms in a Breast Cancer Screening Programme;;
Anton;rutter2017.pdf;Effect of Time to Diagnostic Testing for Breast, Cervical, and Colorectal Cancer Screening Abnormalities on Screening Efficacy: A Modeling Study;;
Noneg;loeve2000.pdf;Endoscopic Colorectal Cancer Screening: a Cost-Saving Analysis;;
Anton;goldwasser2016.pdf;Estimation of the tumor size at cure threshold among aggressive non-small cell lung cancers (NSCLCs): Evidence from The Surveillance, Epidemiology, and End Results Program (SEER) and the National Lung Screening Trial (NLST).;;
Anton;nihms331310.pdf;Long-term Projections of the Number Needed to Screen and Additional Number Needed to Treat in Prostate Cancer Screening;;
Noneg;clries2013.pdf;Predicting the Change in Breast Cancer Deaths in Spain by 2019;;
Noneg;sawaya2003.pdf;Risk of Cervical Cancer Associated with Extending the Interval between Cervical-Cancer Screenings;;
FromReview;lansdorpvogelaar2010.pdf;Stool DNA Testing to Screen for Colorectal Cancer in the Medicare Population;;
Noneg;campos2016.pdf;To Expand Coverage, or Increase Frequency: Quantifying the Tradeoffs between Equity and Efficiency Facing Cervical Cancer Screening Programs in Low-Resource Settings;;
